2,053 results on '"Costello, A"'
Search Results
2. Characterization of hereditary transthyretin cardiac amyloidosis in Spain
- Author
-
Miguel Ángel Aibar Arregui, Marina Martínez Moreno, Gonzalo Barge-Caballero, Javier Limeres Freire, Esther Zorio Grima, Pablo García-Pavía, María Valverde Gómez, María Teresa Bosch Rovira, Juan Jiménez-Jáimez, Mayte Basurte, Idaira Famara Hernández Baldomero, Luis Miguel Rincón Díaz, María Gallego-Delgado, Juan Ramón Gimeno Blanes, Ana García-Álvarez, M. Ángeles Espinosa Castro, Ana José Manovel Sánchez, Jorge Álvarez Rubio, José González-Costello, José Manuel García-Pinilla, Tomás Ripoll-Vera, and Xabier Arana Achaga
- Subjects
Male ,medicine.medical_specialty ,medicine.drug_class ,Cardiac amyloidosis ,Scintigraphy ,Transthyretin ,Transthyretin amyloidosis ,Internal medicine ,medicine ,Natriuretic peptide ,Humans ,Prealbumin ,Heart Failure ,Amyloid Neuropathies, Familial ,biology ,medicine.diagnostic_test ,business.industry ,Amyloidosis ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Treatment ,Spain ,Heart failure ,Cohort ,biology.protein ,Cardiology ,Female ,Cardiomyopathies ,business ,Atrioventricular block - Abstract
Introduction and objectives Hereditary transthyretin amyloidosis (hATTR) is a disease caused by mutations in the transthyretin gene that frequently shows cardiac involvement due to amyloid deposition in the myocardium. Our objective was to identify cardiac involvement in a Spanish cohort. Methods Retrospective multicenter study of patients diagnosed with hATTR with cardiac involvement from Spanish centers. We collected demographic, clinical, and genetic data. Results A total of 181 patients from 26 centers were included (65.2% men, with a median age at diagnosis of 62 years). The most frequent mutations were Val50Met (67.7%) and Val142Ile (12.4%). The main reason for consultation was extracardiac symptoms (69%), mainly neurological. The mean N-terminal pro-B-type natriuretic peptide level was 2145±3586 pg/mL. The most characteristic electrocardiogram findings were a pseudoinfarct pattern (25.9%) and atrioventricular block (25.3%). Mean ventricular thickness was 15.4±4.1mm. Longitudinal strain was reduced in basal segments by 29.4%. Late diffuse subendocardial enhancement was observed in 58.8%. Perugini grade 2 or 3 uptake was observed in 75% of scintigraphy scans. During follow-up, 24.9% of the patients were admitted for heart failure, 34.3% required a pacemaker, and 31.6% required a liver transplant. One third (32.5%) died during follow-up, mainly due to heart failure (28.8%). The presence of non-Val50Met mutations was associated with a worse prognosis. Conclusions HATTR cardiac amyloidosis in Spain shows heterogeneous genetic and clinical involvement. The prognosis is poor, mainly due to cardiac complications. Consequently early diagnosis and treatment are vital.
- Published
- 2022
- Full Text
- View/download PDF
3. Circadian Rhythm, Clock Genes, and Hypertension: Recent Advances in Hypertension
- Author
-
Hannah M. Costello and Michelle L. Gumz
- Subjects
Clinical Trials as Topic ,Suprachiasmatic nucleus ,Circadian clock ,CLOCK Proteins ,Blood Pressure ,Biology ,Article ,Circadian Rhythm ,CLOCK ,Blood pressure ,Gene Expression Regulation ,Circadian Clocks ,Hypertension ,Internal Medicine ,Animals ,Humans ,Circadian rhythm ,Neuroscience ,Antihypertensive Agents - Abstract
Accumulating evidence suggests that the molecular circadian clock is crucial in blood pressure (BP) control. Circadian rhythms are controlled by the central clock, which resides in the suprachiasmatic nucleus of the hypothalamus and peripheral clocks throughout the body. Both light and food cues entrain these clocks but whether these cues are important for the circadian rhythm of BP is a growing area of interest. The peripheral clocks in the smooth muscle, perivascular adipose tissue, liver, adrenal gland, and kidney have been recently implicated in the regulation of BP rhythm. Dysregulation of the circadian rhythm of BP is associated with adverse cardiorenal outcomes and increased risk of cardiovascular mortality. In this review, we summarize the most recent advances in peripheral clocks as BP regulators, highlight the adverse outcomes of disrupted circadian BP rhythm in hypertension, and provide insight into potential future work in areas exploring the circadian clock in BP control and chronotherapy. A better understanding of peripheral clock function in regulating the circadian rhythm of BP will help pave the way for targeted therapeutics in the treatment of circadian BP dysregulation and hypertension.
- Published
- 2021
- Full Text
- View/download PDF
4. Governance of Taxonomic Lists Survey
- Author
-
Lien, Aaron, Garnett, Stephen, Thiele, Kevin, Costello, Mark, van Dijk, Peter, Thomson, Scott, Raz, Lauren, Wambiji, Nina, Pyle, Richard, Nikolaeva, Svetlana, Hobern, Donald, Zhi-Qiang, Zhang, Bao, Yiming, Buckeridge, John, Cigliano, Maria, Ji, Liqiang, Kirk, Paul, Kroh, Andreas, Orrell, Tom, Barik, Saroj, Banki, Olaf, Zachos, Frank, Christidis, Les, and Conix, Stijn
- Subjects
FOS: Computer and information sciences ,Public Administration ,Bioinformatics ,Environmental Studies ,Natural Resources Management and Policy ,Life Sciences ,Public Affairs, Public Policy and Public Administration ,Social and Behavioral Sciences ,Science and Technology Studies ,Environmental Policy ,Natural Resources and Conservation ,Physical Sciences and Mathematics ,Science and Technology Policy ,Biology ,Environmental Sciences - Abstract
Taxonomy is a foundational scientific discipline, shaping not only the work of biologists and ecologists, but also how people see and understand the living world around us. In its most basic form, taxonomy is the science of precise categorization of the diversity of life on Earth into a rigorous system of scientific names and taxonomic concepts that allows for common understanding of the full extent and relationships of this diversity. Like many other scientific disciplines, taxonomy has evolved, developing over the centuries an agreed set of rules, norms, and shared strategies for definition, classification, and nomenclature of the life forms on Earth — what governance scholars would refer to as the “institution of taxonomy.” There are long-established and widely accepted governance systems in place for some aspects of taxonomy, for example the International Code of Zoological Nomenclature, which establishes rules for the establishment and use of scientific names for organisms known as “animals”. Other aspects of taxonomy, including the development and aggregation of species lists, currently lack similar governance institutions. Since the initial development of Linnaean taxonomy, a diversity of approaches have been adopted for critical taxonomic decisions about synonymy and classification, introducing pluralism to taxonomic principles at different levels and resulting in disagreements about species hypotheses and development of species lists. While the basic principles of Linnaean taxonomy—that species are the fundamental units of taxonomy, binomial names of species, the international codes for naming of species—have wide agreement and adherence, there is variation in implementation of the process of taxonomy, such as from application of different species concepts that result in differences in hypothesized species boundaries and potentially overlapping or conflicting species definitions. When developing species lists, these differences can result in inconsistencies from one list to another depending on the preferences of the list developer. For users of species lists, these differences can cause confusion and uncertainty, with potential effects on issues ranging from conservation to medicine (Thomson et al. this issue). Recent debates within the discipline have pointed to the potential benefits of a unified governance system for the development of taxonomic lists across all taxonomic communities leading to a single, accepted list of all life on Earth. To address this challenge, a group of taxonomists, philosophers of science, and governance scholars have established the Working Group on the Governance of Taxonomic Lists under the auspices of the International Union of Biological Sciences to investigate the development of a governance system for the aggregation of a single list of all life on Earth. As a part of this work, the Working Group is conducting a survey of taxonomists, scientists who utilize taxonomy in their work or research, and other users of taxonomic information to determine 1) if there is agreement that a single list is needed, 2) what form such a list should take, and 3) what governance mechanisms are most acceptable to taxonomists and users of taxonomic information. The results of the survey will be published in peer reviewed journals and used to inform the work of the Working Group going forward.
- Published
- 2022
- Full Text
- View/download PDF
5. Athletes with mild COVID-19 illness demonstrate subtle imaging abnormalities without exercise impairment or arrhythmias
- Author
-
Michael D. Flannery, Leah Wright, Nicholas J. Saner, David Griffin, A. Lindqvist, Andrew Garnham, Erin H Howden, Ben Costello, Brian Cowie, Rachel E. Climie, Steve Foulkes, Daniel J. Green, K. Janssens, Andre La Gerche, Imogen Wallace, Elizabeth D Paratz, and Amy Mitchell
- Subjects
2019-20 coronavirus outbreak ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,biology ,Epidemiology ,Athletes ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,MEDLINE ,COVID-19 ,Arrhythmias, Cardiac ,biology.organism_classification ,Internal medicine ,Research Letter ,medicine ,Humans ,AcademicSubjects/MED00200 ,Cardiology and Cardiovascular Medicine ,business ,Exercise - Abstract
[Extract] We recruited every player from a squad of professional basketballers involved in a ‘super-spreader’ event that lead to a majority being infected with COVID-19 following a single training session in Melbourne, Australia. We compared those athletes who tested positive to COVID-19 by polymerase chain reaction diagnostic testing (16 athletes) to athletes who (i) tested negative and (ii) had no symptoms suggestive of COVID-19 infection (n = 8).
- Published
- 2021
- Full Text
- View/download PDF
6. Towards a global list of accepted species II. Consequences of inadequate taxonomic list governance
- Author
-
Donald Hobern, Mark J. Costello, Haylee Weaver, Stephen T. Garnett, Stijn Conix, Peter Paul van Dijk, Richard L. Pyle, Kevin R. Thiele, Les Christidis, Svetlana Nikolaeva, Frank E. Zachos, Zhi-Qiang Zhang, and Scott Thomson
- Subjects
Evolutionary Biology ,Science & Technology ,Global species lists ,Nomenclature ,business.industry ,Corporate governance ,media_common.quotation_subject ,Biodiversity ,Legislation ,Biodiversity informatics ,Biology ,Public relations ,Modernization theory ,Pest management ,Currency ,Medicine ,Quality (business) ,business ,Life Sciences & Biomedicine ,Zoology ,Ecology, Evolution, Behavior and Systematics ,Taxonomy ,media_common ,Pace - Abstract
Species lists are widely used in legislation and regulation to manage and conserve biodiversity. In this paper, we explore the issues caused by the lack of an adequately governed and universally accepted list of the world’s species. These include lack of quality control, duplicated effort, conflicts of interest, lack of currency, and confusion in the scientific use of taxonomic information. If species lists are to fulfill their role efficiently, then the governance systems underlying their creation must keep pace. Fortunately, modernization of species list governance is now possible as a result of advances in biodiversity informatics and two decades of experience working to create the backbone of a global species list.
- Published
- 2021
- Full Text
- View/download PDF
7. Indigenous cultural burning had less impact than wildfire on the threatened Backwater grevillea (
- Author
-
Michelle McKemey, The Banbai Rangers, Maureen (Lesley) Patterson, John Hunter, Malcolm Ridges, Emilie Ens, Cara Miller, Oliver Costello, and Nick Reid
- Subjects
education.field_of_study ,Ecology ,biology ,Agroforestry ,Population ,Biodiversity ,Forestry ,Grevillea scortechinii ,biology.organism_classification ,Indigenous ,Geography ,Threatened species ,Holistic management ,Grevillea ,education ,Protected area - Abstract
Indigenous self-determination, land rights and caring for Country programs are enabling Indigenous peoples across the world to re-establish customary roles in biodiversity conservation and cultural fire management. In Australia, Indigenous-controlled lands form the majority of the protected area estate, harbour almost 60% of listed threatened species and maintain high levels of biodiversity. This study used cross-cultural (Indigenous and Western academic) methods to monitor the impact of Indigenous cultural burning v. wildfire on the threatened plant, Backwater grevillea (Grevillea scortechinii subsp. sarmentosa). Cultural burning resulted in lower mature grevillea mortality and less impact on reproductive output than wildfire. Both fires stimulated a mass germination but the cultural burn preserved a multi-aged population while the wildfire killed 99.6% of mature shrubs. Comparison of fuel load changes resulting from cultural burning, hazard reduction burning and wildfire indicated that fuel loads were reduced by all fire treatments, although the cultural burn was less severe than other fires. Our case study of the Backwater grevillea and its Banbai custodians provides an example where Indigenous rangers have adopted a plant into their cultural management framework. They are conserving this threatened species using culturally driven, holistic management that is locally focused and supported by cross-cultural knowledge.
- Published
- 2021
- Full Text
- View/download PDF
8. Towards a global list of accepted species IV: Overcoming fragmentation in the governance of taxonomic lists
- Author
-
Saroj Kanta Barik, John S. Buckeridge, Svetlana Nikolaeva, Frank E. Zachos, Zhi-Qiang Zhang, Kevin R. Thiele, Scott Thomson, Stephen T. Garnett, Narelle Montgomery, Richard L. Pyle, Olaf Bánki, Donald Hobern, Stijn Conix, Peter Paul van Dijk, Les Christidis, Aaron M. Lien, and Mark J. Costello
- Subjects
Governance system ,Knowledge management ,media_common.quotation_subject ,CONSERVATION ,Biology ,Market fragmentation ,symbols.namesake ,Monocentric governance ,Fragmented governance ,Knowledge commons ,Product (category theory) ,Ecology, Evolution, Behavior and Systematics ,Taxonomy ,media_common ,Structure (mathematical logic) ,Evolutionary Biology ,Science & Technology ,Polycentric governance ,Taxonomic lists ,business.industry ,Corporate governance ,Linnaean taxonomy ,Pluralism (political theory) ,symbols ,business ,Life Sciences & Biomedicine ,Zoology ,Diversity (politics) - Abstract
Governance is the act of governing or organizing, that is a system of rules, norms, or shared strategies to guide or regulate the actions of the governed. Since the initial development of Linnaean taxonomy, a diversity of approaches have been adopted for critical taxonomic decisions, introducing pluralism to taxonomic principles and resulting in disagreements about the development of species lists. These disagreements are in part a product of the fragmented governance structure that has developed for the creation of taxonomic lists. To address these challenges and achieve the goal of a single, accepted list of life on Earth, a new governance structure for the development of taxonomic lists is needed. Here, we introduce three high-level categories of governance structure—fragmentation, monocentric governance, and polycentric governance—which differ in the way decision-making power is distributed and coordinated. We then show the problems caused by the fragmented governance structure currently in place for the development of taxonomic lists and consider the potential for a new approach grounded in either monocentric or polycentric governance. Both monocentric and polycentric approaches have the potential to address the problems inherent in the existing fragmented system. Ultimately, the best governance system for taxonomic lists will be the one that the taxonomic community is prepared to accept.
- Published
- 2021
- Full Text
- View/download PDF
9. Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer
- Author
-
Parminder Singh, Irbaz Bin Riaz, Cassandra N. Moore, Heidi E. Kosiorek, Renee K. Sharpsten, Andrea McNatty, Glenn A. Stewart, Steven R. Hwang, Alan H. Bryce, Thai H. Ho, Jan B. Egan, Miguel Gonzalez Velez, and Brian A. Costello
- Subjects
Male ,0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Tumor suppressor gene ,Ubiquitin-Protein Ligases ,Urology ,Docetaxel ,Androgen deprivation therapy ,03 medical and health sciences ,Prostate cancer ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,medicine ,Humans ,PTEN ,Genes, Tumor Suppressor ,Retrospective Studies ,biology ,business.industry ,Proportional hazards model ,Hazard ratio ,PTEN Phosphohydrolase ,Abiraterone acetate ,Prostatic Neoplasms ,Androgen Antagonists ,medicine.disease ,Hormones ,Retinoblastoma Binding Proteins ,Treatment Outcome ,030104 developmental biology ,chemistry ,030220 oncology & carcinogenesis ,biology.protein ,Tumor Suppressor Protein p53 ,business ,medicine.drug - Abstract
Background Altered tumor suppressor genes (TSG-alt) in prostate cancer are associated with worse outcomes. The prognostic value of TSG-alt in metastatic, hormone-sensitive prostate cancer (M1-HSPC) is unknown. We evaluated the effects of TSG-alt on outcomes in M1-HSPC and their prognostic impact by first-line treatment. Methods We retrospectively identified patients with M1-HSPC at our institution treated with first-line androgen deprivation therapy plus docetaxel (ADT + D) or abiraterone acetate (ADT + A). TSG-alt was defined as any alteration in one or more TSG. The main outcomes were Kaplan–Meier-estimated progression-free survival (PFS) and overall survival, analyzed with the log-rank test. Clinical characteristics were compared with the χ2 test and Kruskal–Wallis rank sum test. Cox regression was used for univariate and multivariable analyses. Results We identified 97 patients with M1-HSPC: 48 (49%) with ADT + A and 49 (51%) with ADT + D. Of 96 patients with data available, 33 (34%) had 1 TSG-alt, 16 (17%) had 2 TSG-alt, and 2 (2%) had 3 TSG-alt. The most common alterations were in TP53 (36%) and PTEN (31%); 6% had RB1 alterations. Median PFS was 13.1 (95% CI, 10.3–26.0) months for patients with normal TSGs (TSG-normal) vs. 7.8 (95% CI, 5.8–10.5) months for TSG-alt (P = 0.005). Median PFS was lower for patients with TSG-alt vs TSG-normal for those with ADT + A (TSG-alt: 8.0 [95% CI, 5.8–13.8] months vs. TSG-normal: 23.2 [95% CI, 13.1–not estimated] months), but not with ADT + D (TSG-alt: 7.8 [95% CI, 5.7–12.9] months vs. TSG-normal: 9.5 [95% CI, 4.8–24.7] months). On multivariable analysis, only TSG-alt predicted worse PFS (hazard ratio, 2.37; 95% CI, 1.42–3.96; P Conclusions The presence of TSG-alt outperforms clinical criteria for predicting early progression during first-line treatment of M1-HSPC. ADT + A was less effective in patients with than without TSG-alt. Confirmation of these findings may establish the need for inclusion of molecular stratification in treatment algorithms.
- Published
- 2021
- Full Text
- View/download PDF
10. Towards a global list of accepted species I. Why taxonomists sometimes disagree, and why this matters
- Author
-
Frank E. Zachos, Paul M. Kirk, Zhi-Qiang Zhang, Saroj Kanta Barik, Peter Paul van Dijk, Aaron M. Lien, Richard L. Pyle, Kevin R. Thiele, Stijn Conix, Mark J. Costello, Stephen T. Garnett, Scott Thomson, and Les Christidis
- Subjects
Documentation ,Phrase ,Taxon ,Variation (linguistics) ,Taxonomy (general) ,medicine ,Map making ,Biological classification ,medicine.symptom ,Biology ,Ecology, Evolution, Behavior and Systematics ,Confusion ,Epistemology - Abstract
Taxonomy—the delimitation, naming, classification and documentation of species and other taxa—is an often-misunderstood discipline. Complex and at times contested, taxonomy occupies a sometimes discomforting intermediate position on a continuum from descriptive to hypothetico-deductive science. Two aspects of taxonomy that are striking to many observers and users are the degree to which taxonomists often disagree, and the degree of taxonomic revisionism (the replacement of one taxonomic classification with another, exemplified by the phrase ‘taxonomists are always changing the names of things’). Disagreements between taxonomists do not usually indicate taxonomic confusion or chaos, but rather often represent valid disagreements over the best, most effective and most meaningful way to interpret, describe and classify one of the most complex systems that scientists seek to describe and characterise—the patterns of variation of life on Earth. One way to partially manage disagreements among taxonomists is to develop a mechanism to synthesise the flux of taxonomic activity into agreed, broadly accepted, authoritative and scientifically robust global lists of the world’s species and other taxa. A sound understanding of some aspects of the nature of taxonomy is needed to appreciate the opportunities, complexities and limitations of the development and maintenance of such lists.
- Published
- 2021
- Full Text
- View/download PDF
11. The gut microbiota as a therapeutic target for obesity: a scoping review
- Author
-
Robert V Bryant, Simon Travis, Samuel C. Forster, Samuel P Costello, and Stephanie Santos-Paulo
- Subjects
Nutrition and Dietetics ,biology ,business.industry ,Probiotics ,Medicine (miscellaneous) ,Disease ,Fecal Microbiota Transplantation ,Gut flora ,Bioinformatics ,biology.organism_classification ,medicine.disease ,Obesity ,Faecal microbiota transplantation ,Gastrointestinal Microbiome ,law.invention ,Positive energy ,Probiotic ,Prebiotics ,law ,Intestinal Microbiome ,Humans ,Medicine ,Microbiome ,business - Abstract
There is mounting evidence that microbiome composition is intimately and dynamically connected with host energy balance and metabolism. The gut microbiome is emerging as a novel target for counteracting the chronically positive energy balance in obesity, a disease of pandemic scale which contributes to >70 % of premature deaths. This scoping review explores the potential for therapeutic modulation of gut microbiota as a means of prevention and/or treatment of obesity and obesity-associated metabolic disorders. The evidence base for interventional approaches which have been shown to affect the composition and function of the intestinal microbiome is summarised, including dietary strategies, oral probiotic treatment, faecal microbiota transplantation and bariatric surgery. Evidence in this field is still largely derived from preclinical rodent models, but interventional studies in obese populations have demonstrated metabolic improvements effected by microbiome-modulating treatments such as faecal microbiota transplantation, as well as drawing attention to the unappreciated role of microbiome modulation in well-established anti-obesity interventions, such as dietary change or bariatric surgery. The complex relationship between microbiome composition and host metabolism will take time to unravel, but microbiome modulation is likely to provide a novel strategy in the limited armamentarium of effective treatments for obesity.
- Published
- 2021
- Full Text
- View/download PDF
12. Elevated Serum Interleukin-1β Levels in Male, but not Female, Collision Sport Athletes with a Concussion History
- Author
-
Daniel Costello, Rhys D. Brady, Mujun Sun, William T O'Brien, Stuart J. McDonald, Zhibin Chen, Richelle Mychasiuk, Terence J. O'Brien, Georgia F Symons, Joshua S Kimpton, Mastura Monif, Brendan P Major, Jesse Bain, and Sandy R. Shultz
- Subjects
Male ,030506 rehabilitation ,Interleukin-1beta ,Physiology ,Positive correlation ,Elevated serum ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Soccer ,Concussion ,medicine ,Humans ,Brain Concussion ,Sex Characteristics ,biology ,business.industry ,Athletes ,Interleukin-18 ,Interleukin ,medicine.disease ,biology.organism_classification ,Pathophysiology ,Interleukin 1β ,Neuroinflammatory Diseases ,Female ,Interleukin 18 ,Neurology (clinical) ,0305 other medical science ,business ,030217 neurology & neurosurgery - Abstract
It is increasingly reported that a history of concussion may be associated with chronic deleterious consequences. While the pathophysiology that contributes to these consequences is not well understood, neuroinflammation is postulated to be critical. Activation of multi-protein complexes termed inflammasomes, a key component of this inflammatory response, has been reported in more severe TBIs; however, it has not been investigated in milder TBIs, such as concussion. This study investigated serum levels of interleukin (IL)-1β and IL-18 (key proteins activated downstream of these inflammasomes) at acute, sub-acute, and chronic time-points post-concussion. We recruited 105 Australian footballers (65 male, 40 female) during the pre-season, then prospectively followed these players for the occurrence of concussion during the season. At baseline, 58 footballers reported a previous concussion history, and 47 reported no previous concussion history. Additionally, 25 players sustained a mid-season concussion and were sampled at 2, 6, and 13 days post-concussion. Serum levels of IL-1β and IL-18 were quantified using highly sensitive Simoa HD-X Analyzer assays. At baseline, IL-1β levels were higher in male, but not female, footballers with a previous concussion history compared with footballers with no concussion history. There was also a positive correlation between years of collision sport participation and IL-18 levels in males. No evidence was found in males or females to indicate that IL-1β or IL-18 levels differed at 2, 6, or 13 days post-concussion. These findings provide novel insights into potential sex-specific physiological consequences of concussion, and suggest that neuroinflammation may be persistent chronically following concussion in male athletes.
- Published
- 2021
- Full Text
- View/download PDF
13. Estimating flying-fox mortality associated with abandonments of pups and extreme heat events during the austral summer of 2019–20
- Author
-
Fiona Major, Rhonda Hansen, Judith Hopper, Lorraine Oliver, Geoff Francis, Desley Prophet, Stephen Brend, Pauline Dunne, Sara Judge, Kylie Coutts-McClelland, Tania Bishop, Natalie Foster, Carole-Ann McGarry, Rachel Brown, Mike Roache, Leah Colefax, Matthew Mo, Janine Davies, Tamsyn Hogarth, Lisa Roberts, Josie Stokes, Kerryn Parry-Jones, Michelle Wallis, Lawrence Pope, Kylie Kaye, Chris Dawe, Sandra Guy, Justin A. Welbergen, Susan Taylor, Garry Daly, Drew Coxon, Michael E. Smith, Linda M. Collins, Chelsea Costello, Hugh Pitty, Audrey Koosmen, Timothy Pearson, Sarah Curran, Kimberly Baker, and Carla-Maree Simmons
- Subjects
0106 biological sciences ,Empirical data ,Ecology ,biology ,Range (biology) ,fungi ,Foraging ,biology.organism_classification ,010603 evolutionary biology ,01 natural sciences ,Pteropus poliocephalus ,Heat stress ,010601 ecology ,Extreme heat ,Geography ,parasitic diseases ,Threatened species ,Flying fox (fish) ,Nature and Landscape Conservation ,Demography - Abstract
Mass mortalities in flying-foxes occur in summers that reach extremely hot temperatures. In this study, we examine the spatiotemporal distributions of mortality from pup abandonments and extreme heat events in Australian flying-fox camps during the 2019–20 summer. We recorded data on flying-fox mortality in known affected camps and applied a standard method to estimate the number of deaths. Pup mortalities from abandonments were recorded in 10 camps in New South Wales. A minimum estimate of 2612 flying-foxes died in pup abandonments, the majority of which occurred in one camp in Bomaderry. Die-offs from extreme heat events were recorded in 40 camps associated with eight separate heat events in south-eastern Australia. A minimum estimate of 72 175 flying-foxes died during these heat events, which all occurred within the range of the threatened grey-headed flying-fox (Pteropus poliocephalus). Further, 409 and 2251 live flying-foxes were taken into care from pup abandonments and heat events respectively. The minimum mortality estimated represents the highest recorded mortality of Australian flying-foxes within a single summer. This highlights a need to restore vegetation in flying-fox foraging areas and camps, address anthropogenic climate change and gather more empirical data to inform heat stress interventions to minimise flying-fox mortalities.
- Published
- 2021
- Full Text
- View/download PDF
14. Investigation of synovial fluid lubricants and inflammatory cytokines in the horse: a comparison of recombinant equine interleukin 1 beta-induced synovitis and joint lavage models
- Author
-
Katherine Caracappa, Bettina Wagner, Amanda R. Watkins, Albert D’Agostino, Marshall J. Colville, Heather Freer, Sydney Schurer, Matthew J. Paszek, Diana C. Fasanello, Claire Read, Heidi L. Reesink, Jin Su, Darko Stefanovski, Emily Costello, and Alicia Rollins
- Subjects
Male ,Pathology ,medicine.medical_treatment ,Veterinary medicine ,Interleukin-1beta ,Osteoarthritis ,Injections, Intra-Articular ,0403 veterinary science ,chemistry.chemical_compound ,Hyaluronic acid ,Synovial Fluid ,Lubrication ,SF600-1100 ,0303 health sciences ,Synovitis ,biology ,04 agricultural and veterinary sciences ,General Medicine ,medicine.anatomical_structure ,Chemokine ,Cytokines ,Female ,medicine.symptom ,Rheology ,Arthrocentesis ,medicine.medical_specialty ,040301 veterinary sciences ,03 medical and health sciences ,Proteoglycan 4 ,medicine ,Synovial fluid ,Animals ,Horses ,Therapeutic Irrigation ,030304 developmental biology ,Glycoproteins ,Inflammation ,General Veterinary ,business.industry ,Research ,Joint effusion ,medicine.disease ,chemistry ,biology.protein ,Lubricin ,Horse Diseases ,Synovial membrane ,business ,Repeated arthrocentesis - Abstract
Background Lameness is a debilitating condition in equine athletes that leads to more performance limitation and loss of use than any other medical condition. There are a limited number of non-terminal experimental models that can be used to study early inflammatory and synovial fluid biophysical changes that occur in the equine joint. Here, we compare the well-established carpal IL-1β-induced synovitis model to a tarsal intra-articular lavage model, focusing on serial changes in synovial fluid inflammatory cytokines/chemokines and the synovial fluid lubricating molecules lubricin/proteoglycan 4 and hyaluronic acid. The objectives of this study were to evaluate clinical signs; synovial membrane and synovial fluid inflammation; and synovial fluid lubricants and biophysical properties in response to carpal IL-1β synovitis and tarsal intra-articular lavage. Results Hyaluronic acid (HA) concentrations, especially high molecular weight HA, and synovial fluid viscosity decreased after both synovitis and lavage interventions. Synovial fluid lubricin concentrations increased 17–20-fold for both synovitis and lavage models, with similar changes in both affected and contralateral joints, suggesting that repeated arthrocentesis alone resulted in elevated synovial fluid lubricin concentrations. Synovitis resulted in a more severe inflammatory response based on clinical signs (temperature, heart rate, respiratory rate, lameness and joint effusion) and clinicopathological and biochemical parameters (white blood cell count, total protein, prostaglandin E2, sulfated glycosaminoglycans, tumor necrosis factor-α and CC chemokine ligands − 2, − 3, − 5 and − 11) as compared to lavage. Conclusions Synovial fluid lubricin increased in response to IL-1β synovitis and joint lavage but also as a result of repeated arthrocentesis. Frequent repeated arthrocentesis is associated with inflammatory changes, including increased sulfated glycosaminoglycan concentrations and decreased hyaluronic acid concentrations. Synovitis results in more significant inflammatory changes than joint lavage. Our data suggests that synovial fluid lubricin, TNF-α, CCL2, CCL3, CCL5, CCL11 and sGAG may be useful biomarkers for synovitis and post-lavage joint inflammation. Caution should be exercised when performing repeated arthrocentesis clinically or in experimental studies due to the inflammatory response and loss of HA and synovial fluid viscosity.
- Published
- 2021
15. The effectiveness of interactive online tutorials in first-year large biology course
- Author
-
Anna Rissanen and Jane M. Costello
- Subjects
Formative assessment ,Medical education ,05 social sciences ,Active learning ,ComputingMilieux_COMPUTERSANDEDUCATION ,050301 education ,0509 other social sciences ,Biology ,050904 information & library sciences ,0503 education ,Course (navigation) ,Mathematics - Abstract
PurposeOnline resources can be helpful for students and can augment the content presented in learning environments. A team consisting of four biologists, a graduate student, instructional designer and media developers collaborated on the design, development and evaluation of first-year biology online tutorials in a Canadian University. The tutorials were designed to address knowledge gaps resulting in low success rates and attrition of first-year students in biology. The decrease in the number of students in STEM has alarmed educators, prompting a call for efforts to increase STEM majors in universities. Large class sizes, such as first year biology with ∼900 registrants annually, with detail-oriented, content-heavy loads, can result in low success rates and attrition.Design/methodology/approachActive learning methods, including online formative assessments, which encourage student engagement in course material, can be effective in large introductory science classes, and thus, the authors provided engagement with tutorial online resources. The authors identified the tutorial topics by analyzing previous years' tests, student feedback and pedagogical research in undergraduate biology. The top five topics identified as common misconceptions or troublesome concepts within the course were selected. Standard instructional design processes were used to produce high-quality online tutorials. Tutorials included learning materials, videos, animations, self-assessments, reflective questions and badges to facilitate deep learning of the topics. Effectiveness of the tutorials was evaluated using quantitative methods and quasi-experimental design to compare the student learning results between the control year (without tutorials) and the year when tutorials were offered. Pre- and posttests measuring conceptual understanding were administered to assess gains in student learning. Additionally, student engagement was measured using the Classroom Survey of Student Engagement (CLASSE), and data from learning management system was collected.FindingsResults of the study show that the tutorials were an effective means of providing supplementary assistance to students as well as fostering a gain in students' levels of engagement with the course. Data analysis indicates that there was a significant increased gain in learning of core concepts in biology. Specifically, using formative online assessments resulted in measurable learning gains in students who participated voluntarily, in comparison to students who chose not to engage in self-paced quiz testing.Originality/valueAs seen from the description earlier, the tutorials, and this project, provide suitable university-level complexity to address specific learning gaps in the first year course. They provide a valuable service to students in terms of representing content in an alternate format and motivating students as they engaged with videos and self-assessment most frequently. The project adds to the teaching and learning environment with respect to program design, mode of delivery and scheduling by providing self-paced tutorials that focus on specific concepts in biology. Students may review these resources whenever and as often as they feel necessary to better master the concepts. This makes the content applicable for the various preferences for approaches to learning and accommodation requirements found in students. Importantly, using formative online assessments resulted in measurable learning gains in students who participated voluntarily, in comparison to students who chose not to engage in self-paced quiz testing.
- Published
- 2021
- Full Text
- View/download PDF
16. Inhibition of Urea Transporter (UT)-B Modulates LPS-Induced Inflammatory Responses in BV2 Microglia and N2a Neuroblastoma Cells
- Author
-
Gavin Stewart, Derek A. Costello, Aimée C. Jones, and Farhana Pinki
- Subjects
0301 basic medicine ,Microglia ,biology ,Urea transporter ,medicine.medical_treatment ,Inflammation ,General Medicine ,Biochemistry ,Nitric oxide ,Cell biology ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,chemistry.chemical_compound ,030104 developmental biology ,0302 clinical medicine ,Cytokine ,medicine.anatomical_structure ,chemistry ,Downregulation and upregulation ,Urea cycle ,medicine ,biology.protein ,Tumor necrosis factor alpha ,medicine.symptom ,030217 neurology & neurosurgery - Abstract
Urea is the major nitrogen-containing product of protein metabolism, and the urea cycle is intrinsically linked to nitric oxide (NO) production via the common substrate L-arginine. Urea accumulates in the brain in neurodegenerative states, including Alzheimer's and Huntington's disease. Urea transporter B (UT-B, SLC14A1) is the primary transport protein for urea in the CNS, identified most abundantly in astrocytes. Moreover, enhanced expression of the Slc14a1 gene has been reported under neurodegenerative conditions. While the role of UT-B in disease pathology remains unclear, UT-B-deficient mice display behavioural impairment coupled with urea accumulation, NO disruption and neuronal loss. Recognising the role of inflammation in neurodegenerative disease pathology, the current short study evaluates the role of UT-B in regulating inflammatory responses. Using the specific inhibitor UTBinh-14, we investigated the impact of UT-B inhibition on LPS-induced changes in BV2 microglia and N2a neuroblastoma cells. We found that UTBinh-14 significantly attenuated LPS-induced production of TNFα and IL-6 from BV2 cells, accompanied by reduced release of NO. While we observed a similar reduction in supernatant concentration of IL-6 from N2a cells, the LPS-stimulated NO release was further augmented by UTBinh-14. These changes were accompanied by a small, but significant downregulation in UT-B expression in both cell types following incubation with LPS, which was not restored by UTBinh-14. Taken together, the current evidence implicates UT-B in regulation of inflammatory responses in microglia and neuronal-like cells. Moreover, our findings offer support for the further investigation of UT-B as a novel therapeutic target for neuroinflammatory conditions.
- Published
- 2021
- Full Text
- View/download PDF
17. Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk
- Author
-
Ye Lu, Chiara Corradi, Manuel Gentiluomo, Evangelina López de Maturana, George E. Theodoropoulos, Susanne Roth, Evaristo Maiello, Luca Morelli, Livia Archibugi, Jakob R. Izbicki, Patricia Sarlós, Vytautas Kiudelis, Martin Oliverius, Mateus Nóbrega Aoki, Yogesh Vashist, Casper H. J. van Eijck, Maria Gazouli, Renata Talar-Wojnarowska, Andrea Mambrini, Raffaele Pezzilli, Bas Bueno-de-Mesquita, Péter Hegyi, Pavel Souček, John P. Neoptolemos, Gregorio Di Franco, Cosimo Sperti, Emanuele F. Kauffmann, Viktor Hlaváč, Faik G. Uzunoğlu, Stefano Ermini, Ewa Małecka-Panas, Maurizio Lucchesi, Giuseppe Vanella, Frederike Dijk, Beatrice Mohelníková-Duchoňová, Franco Bambi, Maria Chiara Petrone, Krzysztof Jamroziak, Feng Guo, Katerina Kolarova, Giovanni Capretti, Anna Caterina Milanetto, Laura Ginocchi, Martin Loveček, Marta Puzzono, Hanneke W. M. van Laarhoven, Silvia Carrara, Audrius Ivanauskas, Konstantinos Papiris, Daniela Basso, Paolo G. Arcidiacono, Ferenc Izbéki, Roger Chammas, Pavel Vodicka, Thilo Hackert, Claudio Pasquali, Maria L. Piredda, Eithne Costello-Goldring, Giulia Martina Cavestro, Andrea Szentesi, Francesca Tavano, Barbara Włodarczyk, Hermann Brenner, Edita Kreivenaite, Xin Gao, Stefania Bunduc, Roel C. H. Vermeulen, Martin A. Schneider, Anna Latiano, Domenica Gioffreda, Sabrina G. G. Testoni, Juozas Kupcinskas, Rita T. Lawlor, Gabriele Capurso, Núria Malats, Daniele Campa, Federico Canzian, Sub IER overig, IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, Internal medicine, Surgery, Lu, Y., Corradi, C., Gentiluomo, M., Lopez de Maturana, E., Theodoropoulos, G. E., Roth, S., Maiello, E., Morelli, L., Archibugi, L., Izbicki, J. R., Sarlos, P., Kiudelis, V., Oliverius, M., Aoki, M. N., Vashist, Y., van Eijck, C. H. J., Gazouli, M., Talar-Wojnarowska, R., Mambrini, A., Pezzilli, R., Bueno-de-Mesquita, B., Hegyi, P., Soucek, P., Neoptolemos, J. P., Di Franco, G., Sperti, C., Kauffmann, E. F., Hlavac, V., Uzunoglu, F. G., Ermini, S., Malecka-Panas, E., Lucchesi, M., Vanella, G., Dijk, F., Mohelnikova-Duchonova, B., Bambi, F., Petrone, M. C., Jamroziak, K., Guo, F., Kolarova, K., Capretti, G., Milanetto, A. C., Ginocchi, L., Lovecek, M., Puzzono, M., van Laarhoven, H. W. M., Carrara, S., Ivanauskas, A., Papiris, K., Basso, D., Arcidiacono, P. G., Izbeki, F., Chammas, R., Vodicka, P., Hackert, T., Pasquali, C., Piredda, M. L., Costello-Goldring, E., Cavestro, G. M., Szentesi, A., Tavano, F., Wlodarczyk, B., Brenner, H., Kreivenaite, E., Gao, X., Bunduc, S., Vermeulen, R. C. H., Schneider, M. A., Latiano, A., Gioffreda, D., Testoni, S. G. G., Kupcinskas, J., Lawlor, R. T., Capurso, G., Malats, N., Campa, D., Canzian, F., Pathology, AII - Cancer immunology, CCA - Cancer biology and immunology, Oncology, and AGEM - Amsterdam Gastroenterology Endocrinology Metabolism
- Subjects
Linkage disequilibrium ,In silico ,pancreatic cancer ,pancreatic ductal adenocarcinoma ,Single-nucleotide polymorphism ,Biology ,QH426-470 ,susceptibility ,genetic polymorphisms ,miRNA ,SDG 3 - Good Health and Well-being ,Pancreatic cancer ,medicine ,Genetics ,SNP ,Genetics(clinical) ,03.02. Klinikai orvostan ,Gene ,Genotyping ,Genetics (clinical) ,Original Research ,Heritability ,medicine.disease ,Molecular Medicine - Abstract
Genetic factors play an important role in the susceptibility to pancreatic cancer (PC). However, established loci explain a small proportion of genetic heritability for PC; therefore, more progress is needed to find the missing ones. We aimed at identifying single nucleotide polymorphisms (SNPs) affecting PC risk through effects on micro-RNA (miRNA) function. We searched in silico the genome for SNPs in miRNA seed sequences or 3 prime untranslated regions (3'UTRs) of miRNA target genes. Genome-wide association data of PC cases and controls from the Pancreatic Cancer Cohort (PanScan) Consortium and the Pancreatic Cancer Case–Control (PanC4) Consortium were re-analyzed for discovery, and genotyping data from two additional consortia (PanGenEU and PANDoRA) were used for replication, for a total of 14,062 cases and 11,261 controls. None of the SNPs reached genome-wide significance in the meta-analysis, but for three of them the associations were in the same direction in all the study populations and showed lower value of p in the meta-analyses than in the discovery phase. Specifically, rs7985480 was consistently associated with PC risk (OR = 1.12, 95% CI 1.07–1.17, p = 3.03 × 10−6 in the meta-analysis). This SNP is in linkage disequilibrium (LD) with rs2274048, which modulates binding of various miRNAs to the 3'UTR of UCHL3, a gene involved in PC progression. In conclusion, our results expand the knowledge of the genetic PC risk through miRNA-related SNPs and show the usefulness of functional prioritization to identify genetic polymorphisms associated with PC risk.
- Published
- 2021
- Full Text
- View/download PDF
18. Biogeography of polychaete worms (Annelida) of the world
- Author
-
Joko Pamungkas, Christopher J. Glasby, and Mark J. Costello
- Subjects
0106 biological sciences ,0303 health sciences ,Polychaete ,Ecology ,Biogeography ,Biodiversity ,Aquatic Science ,Biology ,biology.organism_classification ,010603 evolutionary biology ,01 natural sciences ,03 medical and health sciences ,Global distribution ,Ecology, Evolution, Behavior and Systematics ,030304 developmental biology - Abstract
The global biogeography of polychaete worms has never been assessed previously. In the present study, we studied the world distribution patterns of polychaetes based on datasets obtained from the Global Biodiversity Information Facility, the Ocean Biogeographic Information System and our recently published checklist of Indonesian polychaete species. Polychaete biogeographic regions were visualized using ‘Infomap Bioregions’, and the latitudinal species richness gradient of the animals was examined using 3 metrics, i.e. alpha, gamma and estimated species richness (the last metric was adjusted for sampling bias). We identified 11 major polychaete biogeographic regions. The North Atlantic, Australia and Indonesia were the top 3 species-rich biogeographic regions in the world. The total number of polychaete species was higher in the southern hemisphere (~2100 species, 67 families) than in the northern hemisphere (~1800 species, 75 families) despite significantly more data in the latter (>500000 records compared to >26000 records). Contrary to the classical idea of a unimodal distribution pattern, the latitudinal gradient of polychaetes was generally bimodal with a pronounced dip north of the Equator (15°N). We suggest that the slightly higher peak of species richness in the southern (30°S) than in the northern (60°N) hemisphere reflects higher southern endemicities. These patterns are unlikely to be due to sampling bias but rather represent a natural phenomenon, and we found them most significantly correlated with sea temperature.
- Published
- 2021
- Full Text
- View/download PDF
19. Antibiotic resistance of Helicobacter pylori in Australia and New Zealand: A systematic review and meta‐analysis
- Author
-
Jessica Gehlert, Jonathon P Schubert, Robert V Bryant, Christopher K. Rayner, Samuel P Costello, Ian C. Roberts-Thomson, and Arduino A. Mangoni
- Subjects
medicine.medical_specialty ,medicine.drug_class ,Antibiotics ,Cochrane Library ,Helicobacter Infections ,03 medical and health sciences ,0302 clinical medicine ,Antibiotic resistance ,Clarithromycin ,Metronidazole ,Internal medicine ,Drug Resistance, Bacterial ,Humans ,Medicine ,Helicobacter pylori ,Hepatology ,biology ,business.industry ,Australia ,Gastroenterology ,Amoxicillin ,Tetracycline ,biology.organism_classification ,Anti-Bacterial Agents ,030220 oncology & carcinogenesis ,Meta-analysis ,030211 gastroenterology & hepatology ,business ,Fluoroquinolones ,New Zealand ,medicine.drug - Abstract
OBJECTIVE While the global prevalence of antibiotic-resistant Helicobacter pylori (H. pylori) is increasing, there is much regional variation, and local data are required to guide eradication therapy. We performed a systematic review and meta-analysis to determine rates of H. pylori antibiotic resistance in Australia and New Zealand. STUDY DESIGN Random effects meta-analysis of data from 15 published studies and three published abstracts reporting prevalence of primary or secondary H. pylori antibiotic resistance in Australasia. DATA SOURCES PubMed, EMBASE, MEDLINE, PROSPERO, and the Cochrane Library were searched until August, 2020. DATA SYNTHESIS Fifteen published studies and three published abstracts were identified; one study was excluded due to high risk of bias. Seventeen studies conducted between 1996 and 2013 were included in the final analysis, 12 reporting primary and five reporting secondary antibiotic resistance. Prevalence of primary resistance was clarithromycin 7.4% (95% confidence interval [CI], 5.3-9.7%), metronidazole 50.0% (95%CI, 23.9-56.1%), fluoroquinolones 3.7% (95%CI, 0.004-14.8%), and both amoxicillin and tetracycline
- Published
- 2021
- Full Text
- View/download PDF
20. The Hydrodynamics of Jellyfish Swimming
- Author
-
Kelly R. Sutherland, Kelsey N. Lucas, Brad J. Gemmell, John H. Costello, Sean P. Colin, and John O. Dabiri
- Subjects
0303 health sciences ,Jellyfish ,Scyphozoa ,biology ,Computer science ,Animal mechanics ,Propulsion ,Oceanography ,Models, Biological ,01 natural sciences ,Biomechanical Phenomena ,010305 fluids & plasmas ,03 medical and health sciences ,biology.animal ,0103 physical sciences ,Hydrodynamics ,Animals ,Biochemical engineering ,Swimming ,030304 developmental biology - Abstract
Jellyfish have provided insight into important components of animal propulsion, such as suction thrust, passive energy recapture, vortex wall effects, and the rotational mechanics of turning. These traits are critically important to jellyfish because they must propel themselves despite severe limitations on force production imposed by rudimentary cnidarian muscular structures. Consequently, jellyfish swimming can occur only by careful orchestration of fluid interactions. Yet these mechanics may be more broadly instructive because they also characterize processes shared with other animal swimmers, whose structural and neurological complexity can obscure these interactions. In comparison with other animal models, the structural simplicity, comparative energetic efficiency, and ease of use in laboratory experimentation allow jellyfish to serve as favorable test subjects for exploration of the hydrodynamic bases of animal propulsion. These same attributes also make jellyfish valuable models for insight into biomimetic or bioinspired engineeringof swimming vehicles. Here, we review advances in understanding of propulsive mechanics derived from jellyfish models as a pathway toward the application of animal mechanics to vehicle designs.
- Published
- 2021
- Full Text
- View/download PDF
21. The role of invasive tunicates as reservoirs of molluscan pathogens
- Author
-
Sharon A. Lynch, Sarah C. Culloty, Katie E. Costello, Rob McAllen, and Ruth M. O'Riordan
- Subjects
0106 biological sciences ,Didemnum vexillum ,Oyster ,Ecology ,biology ,010604 marine biology & hydrobiology ,Botrylloides violaceus ,fungi ,Zoology ,Styela clava ,Pacific oyster ,biology.organism_classification ,010603 evolutionary biology ,01 natural sciences ,Bonamia ostreae ,biology.animal ,Crassostrea ,Ostrea edulis ,Ecology, Evolution, Behavior and Systematics - Abstract
Ascidian tunicates frequently display rapid expansion when introduced beyond their native range and are considered successful invaders. This invasive potential may be exacerbated by a warming climate, allowing for the occupation of environmental niches previously held by native species. Research into tunicate invasion ecology is prevalent, but less is known about their role in pathogen maintenance. This study investigated the impact of invasive tunicates on the maintenance of pathogens that affect commercial bivalves, including the cultured species Ostrea edulis (European flat oyster) and Crassostrea gigas (Pacific oyster), and the fished species Cerastoderma edule (Common cockle). Focal pathogens included ostreid herpesvirus OsHV-1 μVar, Vibrio aestuarianus, Bonamia ostreae and Minchinia spp. The range of pathogens in their molluscan hosts was determined and the tunicates Botrylloides violaceus, Didemnum vexillum and Styela clava were then screened for these same pathogens, using both field samples from oyster culture sites and marinas and a series of laboratory cohabitation trials. Sample sites reflected areas close to and further away from known pathogen sources. PCR, Sanger sequencing and histology confirmed the presence of B. ostreae and Minchinia mercenariae-like in S. clava, and V. aestuarianus was confirmed by qPCR in B. violaceus and D. vexillum. Furthermore, histology confirmed Minchinia mercenariae-like sporonts in S. clava suggesting that the tunicate can facilitate replication of this species. S. clava also maintained B. ostreae in tanks with no oysters present. The results indicate that tunicates can act as reservoirs of infection in areas where disease occurs and potentially transport diseases to uninfected sites.
- Published
- 2020
- Full Text
- View/download PDF
22. KDM5A and PHF2 positively control expression of pro-metastatic genes repressed by EWS/Fli1, and promote growth and metastatic properties in Ewing sarcoma
- Author
-
Joseph Hsieh, James C. Costello, Paul Jedlicka, Lays M. Sobral, Chelsea Self, Marybeth Sechler, Andrew Goodspeed, Janet K. Parrish, Kenneth L. Jones, and Tyler S. McCann
- Subjects
0301 basic medicine ,L1 ,Population ,Cell ,Metastasis ,03 medical and health sciences ,0302 clinical medicine ,medicine ,metastasis ,Epigenetics ,education ,education.field_of_study ,epigenetics ,biology ,medicine.disease ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,FLI1 ,KDM5A ,biology.protein ,Cancer research ,Jumonji-domain histone demethylase ,Sarcoma ,Ewing sarcoma ,Research Paper - Abstract
Ewing sarcoma is an aggressive malignant neoplasm with high propensity for metastasis and poor clinical outcomes. The EWS/Fli1 oncofusion is the disease driver in > 90% of cases, but presents a difficult therapeutic target. Moreover, EWS/Fli1 plays a complex role in disease progression, with inhibitory effects on critical steps of metastasis. Like many other pediatric cancers, Ewing sarcoma is a disease marked by epigenetic dysregulation. Epigenetic mechanisms present alternative targeting opportunities, but their contributions to Ewing sarcoma metastasis and disease progression remain poorly understood. Here, we show that the epigenetic regulators KDM5A and PHF2 promote growth and metastatic properties in Ewing sarcoma, and, strikingly, activate expression many pro-metastatic genes repressed by EWS/Fli1. These genes include L1CAM, which is associated with adverse outcomes in Ewing sarcoma, and promotes migratory and invasive properties. KDM5A and PHF2 retain their growth promoting effects in more metastatically potent EWS/Fli1low cells, and PHF2 promotes both invasion and L1CAM expression in this cell population. Furthermore, KDM5A and PHF2 each contribute to the increased metastatic potency of EWS/Fli1low cells in vivo. Together, these studies identify KDM5A and PHF2 as novel disease-promoting factors, and potential new targets, in Ewing sarcoma, including the more metastatically potent EWS/Fli1low cell population.
- Published
- 2020
- Full Text
- View/download PDF
23. Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence
- Author
-
José González-Costello, Ramon M. Pujol, Núria Farré, Nicolás Manito, Miguel Cainzos-Achirica, Antoni Bayes-Genis, Pedro Moliner-Borja, Josep Comin-Colet, Lara Fuentes, Carles Díez-López, Cristina Enjuanes, Josep Lupón, and Marta de Antonio
- Subjects
medicine.medical_specialty ,Anemia ,Iron ,Intravenous iron ,030204 cardiovascular system & hematology ,Ventricular Function, Left ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Internal Medicine ,medicine ,Humans ,In patient ,030212 general & internal medicine ,Aged ,Heart Failure ,Ejection fraction ,Anemia, Iron-Deficiency ,biology ,Safety outcomes ,business.industry ,Iron deficiency ,Stroke Volume ,medicine.disease ,Chronic heart failure ,Ferritin ,Heart failure ,Cohort ,biology.protein ,business - Abstract
Introduction and objectives: Treatment with intravenous iron in patients with heart failure (HF) and iron deficiency (ID) improves symptoms, however its impact on survival and safety is unknown. We aimed to evaluate the management of ID and anemia with intravenous iron in patients with HF and long-term safety of intravenous iron. Methods: We evaluated anemia and ID in patients with chronic HF at 3 university hospitals. Anemia was defined using the World Health Organization definition and ID was defined as ferritin
- Published
- 2020
- Full Text
- View/download PDF
24. Characterization of the Inflammatory Response to Severe COVID-19 Illness
- Author
-
Cora McNally, Tomás P. Carroll, Oisín F. McElvaney, Fiona Kiernan, Sinead Galvin, Orna Ní Choileáin, Oliver J. McElvaney, Mark P Murphy, Killian Hurley, Eoin O'Connor, Alan Gaffney, Fiona Boland, Richard W. Costello, Brian Marsh, Imran Sulaiman, James O'Rourke, P. Branagan, Grace Hogan, Danielle M Dunlea, Ross K. Morgan, Michael Power, Daniel Ryan, Noel G. McElvaney, James Freeman, Cedric Gunaratnam, Natalie L McEvoy, Michael Emmet O'Brien, Eoghan de Barra, Gerard F. Curley, R. Dwyer, Samuel J. McConkey, Caroline Larkin, Seán Walsh, Ruth Aoibheann O’Leary, Pierce Geoghegan, and Jennifer Clarke
- Subjects
Pulmonary and Respiratory Medicine ,Coronavirus disease 2019 (COVID-19) ,immunometabolism ,Disease ,Critical Care and Intensive Care Medicine ,medicine.disease_cause ,03 medical and health sciences ,0302 clinical medicine ,neutrophils ,Severity of illness ,medicine ,030212 general & internal medicine ,COVID-19/Pulmonary Infections ,Interleukin 6 ,Coronavirus ,biology ,business.industry ,Case-control study ,COVID-19 ,Original Articles ,medicine.disease ,cytokines ,Interleukin 10 ,Pneumonia ,030228 respiratory system ,Immunology ,biology.protein ,alpha-1 antitrypsin ,business - Abstract
Rationale: Coronavirus disease (COVID-19) is a global threat to health. Its inflammatory characteristics are incompletely understood. Objectives: To define the cytokine profile of COVID-19 and to identify evidence of immunometabolic alterations in those with severe illness. Methods: Levels of IL-1β, IL-6, IL-8, IL-10, and sTNFR1 (soluble tumor necrosis factor receptor 1) were assessed in plasma from healthy volunteers, hospitalized but stable patients with COVID-19 (COVIDstable patients), patients with COVID-19 requiring ICU admission (COVIDICU patients), and patients with severe community-acquired pneumonia requiring ICU support (CAPICU patients). Immunometabolic markers were measured in circulating neutrophils from patients with severe COVID-19. The acute phase response of AAT (alpha-1 antitrypsin) to COVID-19 was also evaluated. Measurements and Main Results: IL-1β, IL-6, IL-8, and sTNFR1 were all increased in patients with COVID-19. COVIDICU patients could be clearly differentiated from COVIDstable patients, and demonstrated higher levels of IL-1β, IL-6, and sTNFR1 but lower IL-10 than CAPICU patients. COVID-19 neutrophils displayed altered immunometabolism, with increased cytosolic PKM2 (pyruvate kinase M2), phosphorylated PKM2, HIF-1α (hypoxia-inducible factor-1α), and lactate. The production and sialylation of AAT increased in COVID-19, but this antiinflammatory response was overwhelmed in severe illness, with the IL-6:AAT ratio markedly higher in patients requiring ICU admission (P
- Published
- 2020
- Full Text
- View/download PDF
25. Enclosed versus ring feeders: Effects of round-bale feeder type on horse behavior and welfare
- Author
-
Mackenzie V. Melvin, Emily Costello, and Jessica D. Colpoys
- Subjects
Horse behavior ,Animal science ,integumentary system ,General Veterinary ,animal diseases ,embryonic structures ,Agonistic behaviour ,Herd ,Hay ,food and beverages ,Eating behavior ,sense organs ,Biology - Abstract
In an effort to minimize the amount of hay wasted from a round bale, horse owners generally surround the bale with a round-bale feeder. While often necessary as a supplemental feed source, this feeding technique restricts the space each horse has to feed, altering a horse's natural eating behavior. The objective of this study was to evaluate the influence of the round-bale feeder type on stress, agonistic behaviors, and horse preference of feeder types. Two feeder treatments were evaluated: (1) round bale surrounded by a ring feeder (ring feeder; BW Hayhuts LLC, Palm Coast, FL). Two horse herds (n = 5 horses per herd) were evaluated using a crossover experimental design, where each herd received each treatment for one week to evaluate behavior and cortisol concentrations. After this, each herd had access to both feeder treatments at the same time to evaluate preference. Feeding horses with the enclosed feeder resulted in fewer total agonistic threats (P
- Published
- 2020
- Full Text
- View/download PDF
26. Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites
- Author
-
Cheng-Han Chung, Alexander G. Allen, Michael R. Nonnemacher, Greg Homan, Brian Wigdahl, Neil T. Sullivan, Rebekah Madrid, Robert Costello, Andrew Atkins, and Will Dampier
- Subjects
0301 basic medicine ,Biology ,Article ,NF-κB ,03 medical and health sciences ,0302 clinical medicine ,computational biology ,Transcription (biology) ,HIV-1 reservoir ,Drug Discovery ,CRISPR ,Guide RNA ,Binding site ,GUIDE-Seq ,lcsh:RM1-950 ,Promoter ,Provirus ,gene therapy ,Long terminal repeat ,Cell biology ,DNA binding site ,030104 developmental biology ,lcsh:Therapeutics. Pharmacology ,030220 oncology & carcinogenesis ,Molecular Medicine ,CRISPR-Cas9 - Abstract
Viral latency of human immunodeficiency virus type 1 (HIV-1) has become a major hurdle to a cure in the highly effective antiretroviral therapy (ART) era. The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 system has successfully been demonstrated to excise or inactivate integrated HIV-1 provirus from infected cells by targeting the long terminal repeat (LTR) region. However, the guide RNAs (gRNAs) have classically avoided transcription factor binding sites (TFBSs) that are readily observed and known to be important in human promoters. Although conventionally thought unfavorable due to potential impact on human promoters, our computational pipeline identified gRNA sequences that were predicted to inactivate HIV-1 transcription by targeting the nuclear factor κB (NF-κB) binding sites (gNFKB0, gNFKB1) with a high safety profile (lack of predicted or observed human edits) and broad-spectrum activity (predicted coverage of known viral sequences). Genome-wide, unbiased identification of double strand breaks (DSBs) enabled by sequencing (GUIDE-seq) showed that the gRNAs targeting NF-κB binding sites had no detectable CRISPR-induced off-target edits in HeLa cells. 5′ LTR-driven HIV-1 transcription was significantly reduced in three HIV-1 reporter cell lines. These results demonstrate a working model to specifically target well-known TFBSs in the HIV-1 LTR that are readily observed in human promoters to reduce HIV-1 transcription with a high-level safety profile and broad-spectrum activity., Graphical Abstract, CRISPR has demonstrated potential for treating HIV latency. Guide RNA (gRNA) design has conventionally avoided transcription factor binding sites (TFBS) readily observed on the HIV-1 long terminal repeat due to potential impact on human promoters. This study has demonstrated that TFBS on the HIV-1 LTR, specifically NF-κB binding sites, could serve as potential target sites that significantly inactivate HIV-1 transcription. More importantly, these HIV-1-specific gRNAs designed by our custom bioinformatic pipeline did not induce CRISPR-mediated off-target edits in human cells using the genome-wide, unbiased identification of DSBs enabled by sequencing (GUIDE-seq).
- Published
- 2020
27. Remodelling of fibrillin-rich microfibrils by solar-simulated radiation: impact of skin ethnicity
- Author
-
Christopher E.M. Griffiths, Patrick Costello, Poonam Halai, Michael J. Sherratt, Rachel E.B. Watson, Mark Hann, and A.K. Langton
- Subjects
Pathology ,medicine.medical_specialty ,integumentary system ,Solar Simulated Radiation ,Elastic fibre ,Absorption (skin) ,Biology ,medicine.anatomical_structure ,Dermis ,Reticular connective tissue ,Ultrastructure ,medicine ,Physical and Theoretical Chemistry ,Fibrillin ,Reticular Dermis - Abstract
Fibrillin-rich microfibrils (FRMs) constitute integral components of the dermal elastic fibre network with a distinctive ultrastructural 'beads-on-a-string' appearance that can be visualised using atomic force microscopy and characterised by measurement of their length and inter-bead periodicity. Their deposition within the dermis in photoprotected skin appears to be contingent on skin ethnicity, and influences the ultrastructure of papillary - but not reticular - dermal FRMs. Truncation and depletion of FRMs at the dermal-epidermal junction of skin occurs early in photoageing in people with lightly pigmented skin; a process of accelerated skin ageing that arises due to chronic sun exposure. Accumulation of ultraviolet radiation (UVR)-induced damage, either by the action of enzymes, oxidation or direct photon absorption, results in FRM remodelling and changes to ultrastructure. In the current study, the direct effect of UVR exposure on FRM ultrastructure was assayed by isolating FRMs from the papillary and reticular dermis of photoprotected buttock skin of individuals of either black African or white Northern European ancestry and exposing them to solar-simulated radiation (SSR). Exposure to SSR resulted in significant reduction in inter-bead periodicity for reticular dermis-derived FRMs across both cohorts. In contrast, papillary dermal FRMs exhibited significantly increased inter-bead periodicity, with the magnitude of damage greater for African FRMs, as compared to Northern European FRMs. Our data suggest that FRMs of the dermis should be considered as two distinct populations that differentially accrue damage in response to SSR. Furthermore, papillary dermal FRMs derived from black African subjects show greater change following UVR challenge, when extracted from skin. Future studies should focus on understanding the consequences of UVR exposure in vivo, regardless of skin ethnicity, on the molecular composition of FRMs and how this UVR-induced remodelling may affect the role FRMs play in skin homeostasis.
- Published
- 2020
- Full Text
- View/download PDF
28. Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma
- Author
-
Sydney Lastella, David R. Raleigh, Stephen T. Magill, Harish N. Vasudevan, Joseph F. Costello, Philip V. Theodosopoulos, Manish K. Aghi, Benjamin Demaree, Daniel A. Lim, Javier Villanueva-Meyer, Penny K. Sneed, Adam R. Abate, Steve Braunstein, Melike Pekmezci, Sarah Findakly, Michael W. McDermott, Kyounghee Seo, Abrar Choudhury, S. John Liu, Stephanie Hilz, Mitchel S. Berger, Erik M. Ullian, and Nancy Ann Oberheim Bush
- Subjects
0301 basic medicine ,Epigenomics ,Receptor-Like Protein Tyrosine Phosphatases ,General Physics and Astronomy ,medicine.disease_cause ,Gene regulatory networks ,Transcriptome ,0302 clinical medicine ,Meningeal Neoplasms ,2.1 Biological and endogenous factors ,Aetiology ,lcsh:Science ,Cancer ,Multidisciplinary ,medicine.diagnostic_test ,Brain Neoplasms ,Receptor-Like Protein Tyrosine Phosphatases, Class 5 ,Genomics ,Cadherins ,Magnetic Resonance Imaging ,CD ,Female ,Biotechnology ,Cerebral organoid ,Genetic Markers ,Tumour heterogeneity ,Science ,Biology ,General Biochemistry, Genetics and Molecular Biology ,Article ,Meningioma ,03 medical and health sciences ,Genetic Heterogeneity ,Rare Diseases ,Cancer epigenetics ,Antigens, CD ,Genetics ,medicine ,otorhinolaryngologic diseases ,Humans ,Antigens ,neoplasms ,Aged ,Genetic heterogeneity ,Gene Expression Profiling ,Human Genome ,Neurosciences ,Magnetic resonance imaging ,General Chemistry ,medicine.disease ,Class 5 ,Brain Disorders ,nervous system diseases ,Brain Cancer ,CNS cancer ,030104 developmental biology ,Diffusion Magnetic Resonance Imaging ,Cancer research ,lcsh:Q ,Carcinogenesis ,030217 neurology & neurosurgery - Abstract
Meningiomas are the most common primary intracranial tumors, but the molecular drivers of meningioma tumorigenesis are poorly understood. We hypothesized that investigating intratumor heterogeneity in meningiomas would elucidate biologic drivers and reveal new targets for molecular therapy. To test this hypothesis, here we perform multiplatform molecular profiling of 86 spatially-distinct samples from 13 human meningiomas. Our data reveal that regional alterations in chromosome structure underlie clonal transcriptomic, epigenomic, and histopathologic signatures in meningioma. Stereotactic co-registration of sample coordinates to preoperative magnetic resonance images further suggest that high apparent diffusion coefficient (ADC) distinguishes meningioma regions with proliferating cells enriched for developmental gene expression programs. To understand the function of these genes in meningioma, we develop a human cerebral organoid model of meningioma and validate the high ADC marker genes CDH2 and PTPRZ1 as potential targets for meningioma therapy using live imaging, single cell RNA sequencing, CRISPR interference, and pharmacology., Meningiomas are heterogeneous tumours. Here, the authors analysed genetic, epigenetic, and transcriptomic features across spatially-distinct meningioma samples to identify molecular programs underlying tumorigenesis that can be detected preoperatively using magnetic resonance imaging.
- Published
- 2020
- Full Text
- View/download PDF
29. High Serum Vitamin B12 Levels Associated with C-Reactive Protein in Older Patients with Cancer
- Author
-
Patrick Villani, Gaëtan Gentile, Florence Duffaud, Aurélie Daumas, Sébastien Salas, Vincent Pradel, Laure Farnault, Geoffroy Venton, Fabrice Barlesi, Anais Courcier, Anne-Laure Couderc, Robin Arcani, Laurent Greillier, Pierre Suchon, Régis Costello, Eddy Puchades, Assistance Publique - Hôpitaux de Marseille (APHM), Aix-Marseille Université - École de médecine (AMU SMPM MED), Aix-Marseille Université - Faculté des sciences médicales et paramédicales (AMU SMPM), Aix Marseille Université (AMU)-Aix Marseille Université (AMU), Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Service d'oncologie multidisciplinaire innovations thérapeutiques [Hôpital Nord - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital Nord [CHU - APHM], Marseille medical genetics - Centre de génétique médicale de Marseille (MMG), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Aix Marseille Université (AMU), Anthropologie bio-culturelle, Droit, Ethique et Santé (ADES), Aix Marseille Université (AMU)-EFS ALPES MEDITERRANEE-Centre National de la Recherche Scientifique (CNRS), Unité de coordination en oncogériatrie (UCOG Paca ouest), and Lucas, Nelly
- Subjects
Cancer Research ,medicine.medical_specialty ,Activities of daily living ,Palliative care ,Multivariate analysis ,[SDV]Life Sciences [q-bio] ,High serum vitamin B12 levels ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Logistic regression ,[SHS]Humanities and Social Sciences ,C-reactive protein ,03 medical and health sciences ,0302 clinical medicine ,Ambulatory care ,Neoplasms ,Internal medicine ,Activities of Daily Living ,Humans ,Medicine ,030212 general & internal medicine ,[SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biochemistry [q-bio.BM] ,Geriatric Assessment ,Aged ,Aged, 80 and over ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,biology ,business.industry ,[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontology ,Cancer ,Early death ,medicine.disease ,3. Good health ,Hospitalization ,Unplanned hospitalization ,Vitamin B 12 ,Geriatric Oncology ,Oncology ,Geriatric oncology ,030220 oncology & carcinogenesis ,biology.protein ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Older patients with cancer ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
Background A Comprehensive Geriatric Assessment (CGA) has been proposed to assess prognosis and to adapt oncological care in older patients with cancer. However, few biological markers are incorporated in the CGA. Methods This comparative study on older patients with cancer was realized before final therapeutic decision and during a CGA that included biological markers. Our objective study was to know if the serum vitamin B12–C-reactive protein index (BCI) can help to estimate early death and unplanned hospitalization. Associations between BCI and unplanned hospitalization or mortality were analyzed using ordered multivariate logistic regression. Findings We included 621 older cancer adults in outpatient care with a median age of 81 years (range, 70–98 years) from September 2015 to May 2018. In this study, 5.6% of patients died within 3 months, 8.8% had unplanned hospitalization within 1 month, and 11.4% had unplanned hospitalization within 3 months. Hypercobalaminemia was present in 83 patients (13.4%), and 34 patients (5.5%) had BCI >40,000. According to the multivariate analysis, BCI was a prognostic factor of mortality within 3 months and unplanned hospitalizations at 1 and 3 months. Impaired activities of daily living (ADL) and palliative care were also risk factors for mortality within 3 months. Impaired instrumental ADL, low albumin level, and palliative care were risk factors for unplanned hospitalization at 1 month. Interpretation BCI could be routinely added to the CGA process, as part of a pretreatment workup, in order to assess more precisely the frailties and to adapt oncological care in older patients treated for cancer. Implications for Practice Aging comes with an increase of frailties and comorbidities. To identify frailties in older patients with cancer, this study used a Comprehensive Geriatric Assessment, which allowed for the adaptation of each treatment plan in accordance with the individual needs of the patients. However, biological characteristics were not included in this assessment. This study showed that hypercobalaminemia and vitamin B12 -C-reactive protein index may be potential markers for cancer with poor prognosis, particularly in the older population. These biological markers can be used in geriatric oncology and general medicine.
- Published
- 2020
- Full Text
- View/download PDF
30. KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1‐driven and independent disease‐promoting gene expression in fusion‐positive Rhabdomyosarcoma
- Author
-
Tyler S. McCann, Joseph Hsieh, James C. Costello, Paul Jedlicka, Andrew Goodspeed, Lays M. Sobral, Janet K. Parrish, Hannah M. Hicks, and Joshua C. Black
- Subjects
0301 basic medicine ,Jumonji Domain-Containing Histone Demethylases ,Cancer Research ,Oncogene Proteins, Fusion ,genetic structures ,Ets1 ,PAX3 ,Epigenesis, Genetic ,0302 clinical medicine ,Promoter Regions, Genetic ,Rhabdomyosarcoma ,Research Articles ,Forkhead Box Protein O1 ,General Medicine ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,musculoskeletal system ,Phenotype ,Chromatin ,Fusion-Positive Rhabdomyosarcoma ,Gene Expression Regulation, Neoplastic ,Enhancer Elements, Genetic ,Oncology ,030220 oncology & carcinogenesis ,KDM3A ,Molecular Medicine ,Research Article ,musculoskeletal diseases ,Biology ,lcsh:RC254-282 ,Proto-Oncogene Protein c-ets-1 ,03 medical and health sciences ,ETS1 ,Cell Line, Tumor ,Genetics ,medicine ,Humans ,metastasis ,Epigenetics ,PAX3 Transcription Factor ,Transcription factor ,epigenetics ,medicine.disease ,Jumonji ,eye diseases ,030104 developmental biology ,Cancer research ,rhabdomyosarcoma ,Transcriptome ,human activities - Abstract
Fusion‐positive rhabdomyosarcoma (FP‐RMS) is an aggressive pediatric cancer. The chromatin factor KDM3A and the downstream transcription factor Ets1 comprise a new epigenetic axis that works together with, as well as independently of, the driver PAX3/FOXO1 oncofusion to upregulate disease‐promoting gene expression and phenotypic properties in FP‐RMS. These findings offer new insights into potential ways to target aggressive properties in this disease., Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and young adults. RMS exists as two major disease subtypes, oncofusion‐negative RMS (FN‐RMS) and oncofusion‐positive RMS (FP‐RMS). FP‐RMS is characterized by recurrent PAX3/7‐FOXO1 driver oncofusions and is a biologically and clinically aggressive disease. Recent studies have revealed FP‐RMS to have a strong epigenetic basis. Epigenetic mechanisms represent potential new therapeutic vulnerabilities in FP‐RMS, but their complex details remain to be defined. We previously identified a new disease‐promoting epigenetic axis in RMS, involving the chromatin factor KDM3A and the Ets1 transcription factor. In the present study, we define the KDM3A and Ets1 FP‐RMS transcriptomes and show that these interface with the recently characterized PAX3/FOXO1‐driven gene expression program. KDM3A and Ets1 positively control numerous known and candidate novel PAX3/FOXO1‐induced RMS‐promoting genes, including subsets under control of PAX3/FOXO1‐associated superenhancers (SE), such as MEST. Interestingly, KDM3A and Ets1 also positively control a number of known and candidate novel FP‐RMS‐promoting, but not PAX3/FOXO1‐dependent, genes. Epistatically, Ets1 is downstream of, and exerts disease‐promoting effects similar to, both KDM3A and PAX3/FOXO1. MEST also manifests disease‐promoting properties in FP‐RMS, and KDM3A and Ets1 each impacts activation of the PAX3/FOXO1‐associated MEST SE. Taken together, our studies show that the KDM3A/Ets1 epigenetic axis plays an important role in disease promotion in FP‐RMS, and provide insight into potential new ways to target aggressive phenotypes in this disease.
- Published
- 2020
- Full Text
- View/download PDF
31. Lipoteichoic Acid as a Potential Noninvasive Biomarker of Biofilm in Dialysis Access
- Author
-
Sushovita Mukherjee, Michael C. Dean, Alexander S. Yevzlin, Lenar Yessayan, Michael Heung, Matthew D. McGuire, Amy Barton Pai, Karen N. Davidge, Gabrielle Costello, and Ernane Souza
- Subjects
Lipopolysaccharides ,Male ,medicine.medical_specialty ,Prosthesis-Related Infections ,medicine.medical_treatment ,Biomedical Engineering ,Biophysics ,Pilot Projects ,Bioengineering ,030204 cardiovascular system & hematology ,Gastroenterology ,Fibrin ,Biomaterials ,03 medical and health sciences ,Dialysis access ,Arteriovenous Shunt, Surgical ,0302 clinical medicine ,Renal Dialysis ,Internal medicine ,medicine ,Central Venous Catheters ,Humans ,In patient ,Gram-Positive Bacterial Infections ,Aged ,Noninvasive biomarkers ,biology ,business.industry ,Biofilm ,General Medicine ,Middle Aged ,Teichoic Acids ,Catheter ,Treatment Outcome ,030228 respiratory system ,Biofilms ,biology.protein ,Female ,Lipoteichoic acid ,Hemodialysis ,business ,Biomarkers - Abstract
Tunneled central venous catheters (TCVCs) are colonized by Gram-positive organisms and form biofilm. Lipoteichoic acid (LTA) is a Gram-positive cell wall component that can be measured in serum. The purpose of this pilot study was to characterize LTA concentrations in hemodialysis (HD) patients with TCVCs compared to other access types and to evaluate biofilm morphology and microbiology in TCVCs removed by clinical decision. The study enrolled patients with TCVCs (18), grafts (19), and fistulas (18). Blood samples were collected before HD, at 30 minutes, 2 hours, and end of HD. Catheters removed by clinical decision were evaluated by scanning electron microscopy (SEM) for biofilm morphology, and portions of the catheter were cultured. LTA was detectable in all samples and concentrations increased significantly in all access types during HD (p0.05 for all comparisons). Patients with TCVCs that had a30% increase in LTA concentration from baseline also had the greatest rate of increase (slope) compared to grafts and fistulas (p = 0.03 and p = 0.04, respectively). Catheters removed by clinical decision (n = 7) and examined by SEM had deposition of fibrin. Cultures revealed polymicrobial colonization. TCVCs had the highest rate of increase of LTA during HD. Further studies to determine the source of LTA in patients with AVG and AVF are warranted.
- Published
- 2020
- Full Text
- View/download PDF
32. Effects of Pregnancy and Isoniazid Preventive Therapy onMycobacterium tuberculosisInterferon Gamma Response Assays in Women With HIV
- Author
-
Enid Kabugho, Paolo Denti, David W. Haas, Gaerolwe Masheto, Gerhard Theron, Shilpa Naik, Diane Costello, Jyoti S. Mathad, Amita Gupta, Sylvia M LaCourse, Sarah Bradford, Marie F. Pierre, Bonnie Zimmer, Kamunkhwala Gausi, Timothy R. Sterling, Renee Browning, Katie McCarthy, Adriana Weinberg, Tichaona Vhembo, Impaact Study Team, Lisa Aaron, Grace Montepiedra, Blandina T. Mmbaga, and Savita Pahwa
- Subjects
0301 basic medicine ,Microbiology (medical) ,medicine.medical_specialty ,Tuberculosis ,medicine.medical_treatment ,Tuberculin ,HIV Infections ,Mycobacterium tuberculosis ,Interferon-gamma ,03 medical and health sciences ,0302 clinical medicine ,Latent Tuberculosis ,Pregnancy ,Internal medicine ,Isoniazid ,medicine ,Humans ,030212 general & internal medicine ,Online only Articles ,Latent tuberculosis ,biology ,Tuberculin Test ,business.industry ,bacterial infections and mycoses ,medicine.disease ,biology.organism_classification ,030104 developmental biology ,Infectious Diseases ,Interpersonal psychotherapy ,Female ,business ,Interferon-gamma Release Tests ,Postpartum period ,medicine.drug - Abstract
BackgroundPregnancy is accompanied by immune suppression. We hypothesized that Mycobacterium tuberculosis-specific inflammatory responses used to identify latent tuberculosis infection (LTBI) lose positivity during pregnancy. We also hypothesized that isoniazid preventive therapy (IPT) may revert LTBI diagnoses because of its sterilizing activity.Methods944 women with human immunodeficiency virus infection (HIV) participating in a randomized, double-blind, placebo-controlled study comparing 28 weeks of IPT antepartum versus postpartum, were tested by QuantiFERON-gold-in-tube (QGIT) antepartum and by QGIT and tuberculin skin test (TST) at delivery and postpartum. Serial QGIT positivity was assessed by logistic regression using generalized estimating equations.ResultsFrom entry to delivery, 68 (24%) of 284 QGIT-positive women reverted to QGIT-negative or indeterminate. Of these, 42 (62%) recovered QGIT positivity postpartum. The loss of QGIT positivity during pregnancy was explained by decreased interferon gamma (IFNγ) production in response to TB antigen and/or mitogen. At delivery, LTBI was identified by QGIT in 205 women and by TST in 113 women. Corresponding numbers postpartum were 229 and 122 women. QGIT and TST kappa agreement coefficients were 0.4 and 0.5, respectively. Among QGIT-positive women antepartum or at delivery, 34 (12%) reverted to QGIT-negative after IPT. There were no differences between women who initiated IPT antepartum or postpartum.ConclusionsDecreased IFNγ responses in pregnancy reduced QGIT positivity, suggesting that this test cannot reliably rule out LTBI during pregnancy. TST was less affected by pregnancy, but had lower positivity compared to QGIT at all time points. IPT was associated with loss of QGIT positivity, the potential clinical consequences of which need to be investigated.
- Published
- 2020
- Full Text
- View/download PDF
33. Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers
- Author
-
Franklin W. Huang, Pablo Tamayo, Thomas R. Cech, Josh Lewis Stern, Sarah E. Ferrara, James C. Costello, Kevin Hu, Grace Hibshman, and William Kim
- Subjects
0301 basic medicine ,MAPK/ERK pathway ,Cancer Research ,Telomerase ,Mutant ,medicine.disease_cause ,0302 clinical medicine ,Neoplasms ,Tumor Microenvironment ,2.1 Biological and endogenous factors ,Gene Regulatory Networks ,Aetiology ,Extracellular Signal-Regulated MAP Kinases ,Promoter Regions, Genetic ,Cancer ,Mutation ,Tumor ,Gene Expression Regulation, Neoplastic ,Oncology ,030220 oncology & carcinogenesis ,Sequence Analysis ,Chromatin Immunoprecipitation ,Epithelial-Mesenchymal Transition ,Oncology and Carcinogenesis ,Biology ,Article ,Cell Line ,Promoter Regions ,Small Molecule Libraries ,03 medical and health sciences ,Genetic ,Cell Line, Tumor ,Genetics ,medicine ,Humans ,Oncology & Carcinogenesis ,Molecular Biology ,Transcription factor ,Neoplastic ,Sequence Analysis, RNA ,Gene Expression Profiling ,SNAI2 ,030104 developmental biology ,Gene Expression Regulation ,Cell culture ,SNAI1 ,Cancer research ,RNA ,Generic health relevance ,Developmental Biology - Abstract
In a substantial fraction of cancers TERT promoter (TERTp) mutations drive expression of the catalytic subunit of telomerase, contributing to their proliferative immortality. We conducted a pan-cancer analysis of cell lines and find a TERTp mutation expression signature dominated by epithelial-to-mesenchymal transition and MAPK signaling. These data indicate that TERTp mutants are likely to generate distinctive tumor microenvironments and intercellular interactions. Analysis of high-throughput screening tests of 546 small molecules on cell line growth indicated that TERTp mutants displayed heightened sensitivity to specific drugs, including RAS pathway inhibitors, and we found that inhibition of MEK1 and 2, key RAS/MAPK pathway effectors, inhibited TERT mRNA expression. Consistent with an enrichment of mesenchymal states in TERTp mutants, cell lines and some patient tumors displayed low expression of the central adherens junction protein E-cadherin, and we provide evidence that its expression in these cells is regulated by MEK1/2. Several mesenchymal transcription factors displayed elevated expression in TERTp mutants including ZEB1 and 2, TWIST1 and 2, and SNAI1. Of note, the developmental transcription factor SNAI2/SLUG was conspicuously elevated in a significant majority of TERTp-mutant cell lines, and knock-down experiments suggest that it promotes TERT expression. Implications: Cancers harboring TERT promoter mutations are often more lethal, but the basis for this higher mortality remains unknown. Our study identifies that TERTp mutants, as a class, associate with a distinct gene and protein expression signature likely to impact their biological and clinical behavior and provide new directions for investigating treatment approaches for these cancers.
- Published
- 2020
- Full Text
- View/download PDF
34. Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
- Author
-
Pedro A. Perez-Mancera, Brian Lane, Mehdi Jalali, Triantafillos Liloglou, Phoebe A. Phillips, John F. Timms, John P. Neoptolemos, Christopher Halloran, Fiona Campbell, William Greenhalf, Milton Ashworth, Eithne Costello, Rebecca Dawson, Anthony Evans, Zipeng Lu, Timothy Andrews, Lawrence N. Barrera, Frances Oldfield, Sarah Brumskill, and Quentin M. Nunes
- Subjects
0301 basic medicine ,Cancer Research ,Stromal cell ,endocrine system diseases ,Adenocarcinoma ,Transforming Growth Factor beta1 ,03 medical and health sciences ,0302 clinical medicine ,Stroma ,Cell Movement ,microRNA ,Tumor Cells, Cultured ,medicine ,Humans ,Fibroblast ,Cell Proliferation ,biology ,Cell growth ,Tenascin C ,Wnt signaling pathway ,Tenascin ,Cell migration ,Fibroblasts ,digestive system diseases ,Gene Expression Regulation, Neoplastic ,Pancreatic Neoplasms ,MicroRNAs ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,biology.protein ,Cancer research ,Carcinoma, Pancreatic Ductal - Abstract
Although fibrotic stroma forms an integral component of pancreatic diseases, whether fibroblasts programmed by different types of pancreatic diseases are phenotypically distinct remains unknown. Here, we show that fibroblasts isolated from patients with pancreatic ductal adenocarcinoma (PDAC), chronic pancreatitis (CP), periampullary tumors, and adjacent normal (NA) tissue (N = 34) have distinct mRNA and miRNA profiles. Compared with NA fibroblasts, PDAC-associated fibroblasts were generally less sensitive to an antifibrotic stimulus (NPPB) and more responsive to positive regulators of activation such as TGFβ1 and WNT. Of the disease-associated fibroblasts examined, PDAC- and CP-derived fibroblasts shared greatest similarity, yet PDAC-associated fibroblasts expressed higher levels of tenascin C (TNC), a finding attributable to miR-137, a novel regulator of TNC. TNC protein and transcript levels were higher in PDAC tissue versus CP tissue and were associated with greater levels of stromal activation, and conditioned media from TNC-depleted PDAC-associated fibroblasts modestly increased both PDAC cell proliferation and PDAC cell migration, indicating that stromal TNC may have inhibitory effects on PDAC cells. Finally, circulating TNC levels were higher in patients with PDAC compared with CP. Our characterization of pancreatic fibroblast programming as disease-specific has consequences for therapeutic targeting and for the manner in which fibroblasts are used in research. Significance: Primary fibroblasts derived from various types of pancreatic diseases possess and retain distinct molecular and functional characteristics in culture, providing a series of cellular models for treatment development and disease-specific research.
- Published
- 2020
- Full Text
- View/download PDF
35. Ink Release and Swimming Behavior in the Oceanic Ctenophore Eurhamphaea vexilligera
- Author
-
Brad J. Gemmell, Kelly R. Sutherland, J. H. Costello, Sean P. Colin, and James P. Townsend
- Subjects
Gulf Stream ,Gelatinous zooplankton ,Oceanography ,biology ,Biological dispersal ,Underwater ,General Agricultural and Biological Sciences ,biology.organism_classification - Abstract
Of the more than 150 ctenophore species, the oceanic ctenophore Eurhamphaea vexilligera is notable for its bright orange-yellow ink, secreted from numerous small vesicles that line its substomodeal comb rows. To date, in situ observations by scuba divers have proved the most fruitful method of observing these animals' natural behavior. We present the results of one such contemporary scuba-based observation of E. vexilligera, conducted in the Gulf Stream waters off the coast of Florida, using high-resolution photography and video. Utilizing underwater camera systems purpose built for filming gelatinous zooplankton, we observed E. vexilligera ink release and swimming behavior in situ. From these data, we describe the timeline and mechanics of E. vexilligera ink release in detail, as well as the animal's different swimming behaviors and resulting ink dispersal patterns. We also describe a rolling swimming behavior, accompanied and possibly facilitated by a characteristic change in overall body shape. These observations provide further insight into the behavioral ecology of this distinctive ctenophore and may serve as the foundation for future kinematic studies.
- Published
- 2020
- Full Text
- View/download PDF
36. Global biogeography of marine amphipod crustaceans: latitude, regionalization, and beta diversity
- Author
-
Mark J. Costello and Tri Arfianti
- Subjects
0106 biological sciences ,0303 health sciences ,Ecology ,biology ,Biogeography ,fungi ,Beta diversity ,Biodiversity ,Species diversity ,Aquatic Science ,biology.organism_classification ,010603 evolutionary biology ,01 natural sciences ,Crustacean ,Latitude ,03 medical and health sciences ,Geography ,Biological dispersal ,Species richness ,Ecology, Evolution, Behavior and Systematics ,030304 developmental biology - Abstract
Studying the biogeography of amphipod crustaceans is of interest because they play an important role at lower trophic levels in ecosystems. Because they lack a planktonic larval stage, it has been hypothesized that marine benthic amphipod crustaceans may have short dispersal distances, high endemicity, and spatial turnover in species composition, and consequently high global species richness. In this study, we examined over 400000 distribution records of 4876 amphipod species, and identified 12 regions of endemicity. The number and percent of endemic species peaked at 30°-35°S and coincided with 3 of these regions of high endemicity: Australia, New Zealand, and southern Africa. Pelagic species of marine amphipod crustaceans were more cosmopolitan than benthic species. The latitudinal patterns of richness (alpha, gamma, and ES50) and species turnover were at least bimodal. Most occurrence records and greater alpha and gamma richness were in mid-latitudes, reflecting sampling bias. Both ES50 and beta diversity had similar richness in the tropics, mid-latitudes, and on the Antarctic shelf around 70°S. These 2 indices exhibited a sharp dip in the deep Southern Ocean at 55°S. ES50 peaked at 30°-35°S and a small dip was apparent near the equator at 5°-10°N. Beta diversity was driven mostly by turnover rather than nestedness. These findings support the need for conservation in each realm of species endemicity—and for amphipods, particularly in Antarctica and the coastal mid-latitudes (30°-35°S) of the Southern Hemisphere.
- Published
- 2020
- Full Text
- View/download PDF
37. Alkalinity movement down acid soil columns was faster when lime and plant residues were combined than when either was applied separately
- Author
-
Clayton R. Butterly, Guangdi Li, Dominic Lauricella, Brendon Costello, Caixian Tang, and Peter Sale
- Subjects
Crop residue ,biology ,Chemistry ,Alkalinity ,Soil Science ,04 agricultural and veterinary sciences ,010501 environmental sciences ,engineering.material ,biology.organism_classification ,01 natural sciences ,Vicia villosa ,Agronomy ,Soil pH ,Soil water ,040103 agronomy & agriculture ,engineering ,0401 agriculture, forestry, and fisheries ,Soil horizon ,Leaching (agriculture) ,0105 earth and related environmental sciences ,Lime - Abstract
Subsurface soil acidity is a serious constraint to crop production and is inherently difficult to correct through conventional application of lime. Thus, new approaches to ameliorate subsurface soil acidity are needed. A column leaching experiment was established to determine whether the plant residues, when combined with lime, could facilitate lime dissolution and alkalinity movement down soil columns (10 cm in diameter × 45 cm long) to ameliorate acid subsurface soil layers. Five plant residues from canola (Brassica nappus L.), field pea (Pisum sativum L.), lucerne (Medicago sativa L.), oats (Avena sativa L.) and vetch (Vicia villosa L.) (C/N ratios of 52, 13, 16, 53 and 12, respectively) were mixed with soil (18 g dry matter kg−1) in the top of soil columns (0–10 cm) either limed (target pH 7 in CaCl2) or non-limed and incubated for 3 months at 25°C. Soil columns were leached six times over the 3-month incubation period and destructively sampled at 1 and 3 months for chemical analysis. The soil amended with plant residues created favourable pH gradients and facilitated downward movement of alkalinity when lime was added. However, net increases in pH in the 10–12-cm layer after 3 months were only observed in two non-legume residue-amended treatments (canola and oat residues, 0.22–0.43 pH unit increase), but not in three legume residue-amended treatments (field pea, lucerne and vetch residues), although those treatments had the greatest pH increase in the short term (1 month). In conclusion, surface incorporation of lime in combination with plant residues accelerated the amelioration of subsurface acidity in the immediate zone (10–12 cm) below the amended layer. Canola and oat residues were superior in terms of increased soil pH over a longer term (3 months), possibly due to their higher C/N ratios. Highlights: Can plant residues, combined with lime, facilitate alkalinity movement down soil columns? Few studies have examined leaching, alkalinity movement and pH gradients using agricultural soils. Lucerne and vetch had the greatest pH increase (1 month) but canola and oat persisted (3 months). Alkalinity movement was faster when lime and plant residues were combined than when applied alone.
- Published
- 2020
- Full Text
- View/download PDF
38. Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma
- Author
-
Bradley C. Leibovich, Daniel J. Serie, Brian A. Costello, Alexander S. Parker, Jeanette E. Eckel-Passow, Eugene D. Kwon, Thai H. Ho, R. Houston Thompson, Haidong Dong, and John C. Cheville
- Subjects
Male ,0301 basic medicine ,Oncology ,Cancer Research ,Programmed Cell Death 1 Receptor ,Kaplan-Meier Estimate ,Kidney ,Nephrectomy ,B7-H1 Antigen ,0302 clinical medicine ,PD-1 ,Original Research ,Cancer Biology ,biology ,Middle Aged ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RCC ,Kidney Neoplasms ,Gene Expression Regulation, Neoplastic ,B7-H1 ,030220 oncology & carcinogenesis ,Immunohistochemistry ,Female ,Adult ,PD-L1 ,medicine.medical_specialty ,Concordance ,Metastatic tumor ,Tumor heterogeneity ,lcsh:RC254-282 ,Genetic Heterogeneity ,03 medical and health sciences ,Internal medicine ,Cox proportional hazards regression ,Biomarkers, Tumor ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Carcinoma, Renal Cell ,Aged ,business.industry ,ccRCC ,Metastasectomy ,medicine.disease ,Survival Analysis ,Clear cell renal cell carcinoma ,030104 developmental biology ,biology.protein ,business - Abstract
Objectives Previous studies noted discordance of programmed death‐1 (PD‐1) and one of its ligands (PD‐L1) across patient‐matched primary and metastatic clear cell renal cell carcinoma (ccRCC). There are inconsistencies if the primary or metastatic tumor has higher expression, and whether metastatic tumor expression is associated with patient outcome. Thus, we examined PD‐1 and PD‐L1 in patient‐matched tumors using a large number of ccRCC patients with long follow‐up. Materials and Methods We analyzed PD‐1 and PD‐L1 using immunohistochemistry in patient‐matched primary and metastatic tumors from 110 ccRCC patients. Concordance was assessed among longitudinal metastatic tumors, as well as across patient‐matched primary and metastatic tumors. Cox proportional hazards regression was used to evaluate the associations of metastatic tumor expression with cancer‐specific survival. Results We observed inter‐metastatic tumor heterogeneity of PD‐1 in 25 (69%) of the 36 patients and of PD‐L1 in seven (19%) patients. Concordance between patient‐matched primary and metastatic tumors was 73% (Kappa = 0.16, 95% CI: −0.003‐0.32). Similarly, concordance of PD‐L1 between metastatic and patient‐matched primary tumors was 78% (Kappa = 0.27, 95% CI: 0.09‐0.46). Both markers demonstrated higher expression in primary vs metastatic tumors. Metastatic tumor expression of PD‐1 was significantly associated with metastatic location (P, We examined PD‐1 and PD‐L1 in patient‐matched tumors in a large cohort of ccRCC with long‐term follow‐up. The expression of PD‐1 and PD‐L1 was discordant across patient‐matched ccRCC tumors, with higher expression in primary tumors. Higher PD‐1 expression was associated with metastatic location and lower cancer‐specific survival.
- Published
- 2020
39. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
- Author
-
Maria Margarida Cunha, Gabriela Schmajuk, Rebecca Hasseli, Namrata Singh, Tiffany Y.T. Hsu, Milena A. Gianfrancesco, Anja Strangfeld, Ranjeny Thomas, Naomi J Patel, Thierry Thomas, Philippe Dieudé, Kimme L. Hyrich, Emily Sirotich, Laura Trupin, Liselotte Tidblad, Jinoos Yazdany, René Marc Flipo, Licia Maria Henrique da Mota, Andrea M Seet, Samar Al Emadi, Carolina A. Isnardi, Saskia Lawson-Tovey, Alí Duarte-García, Hendrik Schulze-Koops, Manuel F. Ugarte-Gil, Vanessa L. Kronzer, Philip Robinson, Lindsay Jacobsohn, Elsa F Mateus, Pedro Machado, Ana Paula Monteiro Gomides, Jean W. Liew, Guillermo A. Berbotto, Miguel Bernardes, Patricia P. Katz, Martin Schäfer, Guillermo J. Pons-Estel, Ulf Müller-Ladner, Jeffrey A. Sparks, Elena Nikiphorou, Christof Specker, Paul Sufka, Zara Izadi, Loreto Carmona, Stephanie Rush, Sandra Lúcia Euzébio Ribeiro, Maria O Valenzuela-Almada, Kristin M. D’Silva, Emily L Gilbert, Raphaèle Seror, Laure Gossec, Beth I Wallace, Viviane Angelina de Souza, Akpabio Akpabio, Jérôme Avouac, Leanna Wise, Wendy Costello, Zachary S. Wallace, Suleman Bhana, Jonathan S. Hausmann, Lianne Kearsley-Fleet, Bernd Raffeiner, Carlo Alberto Scirè, Rebecca Grainger, Sparks, J, Wallace, Z, Seet, A, Gianfrancesco, M, Izadi, Z, Hyrich, K, Strangfeld, A, Gossec, L, Carmona, L, Mateus, E, Lawson-Tovey, S, Trupin, L, Rush, S, Katz, P, Schmajuk, G, Jacobsohn, L, Wise, L, Gilbert, E, Duarte-Garcia, A, Valenzuela-Almada, M, Pons-Estel, G, Isnardi, C, Berbotto, G, Hsu, T, D'Silva, K, Patel, N, Kearsley-Fleet, L, Schafer, M, Ribeiro, S, Al Emadi, S, Tidblad, L, Scire, C, Raffeiner, B, Thomas, T, Flipo, R, Avouac, J, Seror, R, Bernardes, M, Cunha, M, Hasseli, R, Schulze-Koops, H, Muller-Ladner, U, Specker, C, De Souza, V, Da Mota, L, Gomides, A, Dieude, P, Nikiphorou, E, Kronzer, V, Singh, N, Ugarte-Gil, M, Wallace, B, Akpabio, A, Thomas, R, Bhana, S, Costello, W, Grainger, R, Hausmann, J, Liew, J, Sirotich, E, Sufka, P, Robinson, P, Machado, P, and Yazdany, J
- Subjects
Male ,medicine.medical_specialty ,abatacept ,Coronavirus disease 2019 (COVID-19) ,Immunology ,tumour necrosis factor inhibitors ,tumour necrosis factor inhibitor ,Antirheumatic Agents/therapeutic use ,Rheumatoid Arthritis ,Severity of Illness Index ,General Biochemistry, Genetics and Molecular Biology ,Arthritis, Rheumatoid ,03 medical and health sciences ,0302 clinical medicine ,rituximab ,Rheumatology ,Arthritis, Rheumatoid/complications ,Internal medicine ,medicine ,Immunology and Allergy ,Humans ,030212 general & internal medicine ,Registries ,Interleukin 6 ,Aged ,030203 arthritis & rheumatology ,biology ,business.industry ,SARS-CoV-2 ,Abatacept ,Confounding ,COVID-19 ,rheumatoid arthriti ,Middle Aged ,medicine.disease ,Drug class ,Rheumatoid arthritis ,Antirheumatic Agents ,COVID-19/complications ,biology.protein ,Rituximab ,Female ,business ,medicine.drug - Abstract
ObjectiveTo investigate baseline use of biologic or targeted synthetic (b/ts) disease-modifying antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA).MethodsWe analysed the COVID-19 Global Rheumatology Alliance physician registry (from 24 March 2020 to 12 April 2021). We investigated b/tsDMARD use for RA at the clinical onset of COVID-19 (baseline): abatacept (ABA), rituximab (RTX), Janus kinase inhibitors (JAKi), interleukin 6 inhibitors (IL-6i) or tumour necrosis factor inhibitors (TNFi, reference group). The ordinal COVID-19 severity outcome was (1) no hospitalisation, (2) hospitalisation without oxygen, (3) hospitalisation with oxygen/ventilation or (4) death. We used ordinal logistic regression to estimate the OR (odds of being one level higher on the ordinal outcome) for each drug class compared with TNFi, adjusting for potential baseline confounders.ResultsOf 2869 people with RA (mean age 56.7 years, 80.8% female) on b/tsDMARD at the onset of COVID-19, there were 237 on ABA, 364 on RTX, 317 on IL-6i, 563 on JAKi and 1388 on TNFi. Overall, 613 (21%) were hospitalised and 157 (5.5%) died. RTX (OR 4.15, 95% CI 3.16 to 5.44) and JAKi (OR 2.06, 95% CI 1.60 to 2.65) were each associated with worse COVID-19 severity compared with TNFi. There were no associations between ABA or IL6i and COVID-19 severity.ConclusionsPeople with RA treated with RTX or JAKi had worse COVID-19 severity than those on TNFi. The strong association of RTX and JAKi use with poor COVID-19 outcomes highlights prioritisation of risk mitigation strategies for these people.
- Published
- 2021
- Full Text
- View/download PDF
40. Regulating peroxisome–ER contacts via the ACBD5-VAPB tether by FFAT motif phosphorylation and GSK3β
- Author
-
Christian Hacker, Suzan Kors, Emily J.A. Kitchener, Renate Maier, Joseph L. Costello, Michael Schrader, Bettina Warscheid, Lena Reimann, and Chloe Bolton
- Subjects
Protein domain ,Amino Acid Motifs ,Vesicular Transport Proteins ,Endoplasmic Reticulum ,Biochemistry ,Article ,Cell Line ,Mice ,Phosphoserine ,Peroxisomes ,Animals ,Humans ,Phosphorylation ,Glycogen synthase ,Adaptor Proteins, Signal Transducing ,Organelles ,Glycogen Synthase Kinase 3 beta ,biology ,Chemistry ,Endoplasmic reticulum ,Membrane and Lipid Biology ,Membrane Proteins ,Cell Biology ,VAPB ,Peroxisome ,Cell biology ,Major sperm protein ,Membrane ,Mutation ,biology.protein ,Protein Binding - Abstract
Kors et al. reveal that peroxisome–ER associations via the ACBD5-VAPB tether are regulated by phosphorylation and GSK3β in mammalian cells. Phosphorylation sites in the FFAT-like motif of ACBD5 affect the binding to VAPB—and thus peroxisome–ER contact sites—differently., Peroxisomes and the endoplasmic reticulum (ER) cooperate in cellular lipid metabolism. They form membrane contacts through interaction of the peroxisomal membrane protein ACBD5 (acyl-coenzyme A–binding domain protein 5) and the ER-resident protein VAPB (vesicle-associated membrane protein–associated protein B). ACBD5 binds to the major sperm protein domain of VAPB via its FFAT-like (two phenylalanines [FF] in an acidic tract) motif. However, molecular mechanisms, which regulate formation of these membrane contact sites, are unknown. Here, we reveal that peroxisome–ER associations via the ACBD5-VAPB tether are regulated by phosphorylation. We show that ACBD5-VAPB binding is phosphatase-sensitive and identify phosphorylation sites in the flanking regions and core of the FFAT-like motif, which alter interaction with VAPB—and thus peroxisome–ER contact sites—differently. Moreover, we demonstrate that GSK3β (glycogen synthase kinase-3 β) regulates this interaction. Our findings reveal for the first time a molecular mechanism for the regulation of peroxisome–ER contacts in mammalian cells and expand the current model of FFAT motifs and VAP interaction.
- Published
- 2022
- Full Text
- View/download PDF
41. Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
- Author
-
Jose Nativi-Nicolau, Alfonso Siu, Angela Dispenzieri, Mathew S. Maurer, Claudio Rapezzi, Arnt V. Kristen, Pablo Garcia-Pavia, Samantha LoRusso, Márcia Waddington-Cruz, Olivier Lairez, Ronald Witteles, Doug Chapman, Leslie Amass, Martha Grogan, Fabio Adrian Barroso, Johan Van Cleemput, Nowell Fine, Hartmut Schmidt, Burkhard Gess, Henning Moelgaard, Violaine Planté-Bordeneuve, David Adams, Jocelyn Inamo, Giuseppe Vita, Calogero Lino Cirami, Marco Luigetti, Michele Emdin, Yoshiki Sekijima, Taro Yamashita, Eun-Seok Jeon, Maria Alejandra Gonzalez Duarte Briseno, Hans Nienhuis, Olga Azevedo, Josep Maria Campistol Plana, Juan Gonzalez Moreno, Jose Gonzalez Costello, Jonas Wixner, Yesim Parman, Sanjiv Shah, Dianna Quan, Tessa Marburger, Michael Polydefkis, Stephen Gottlieb, Jeffrey Ralph, Nitasha Sarswat, Jin Luo, Srinivas Murali, William Cotts, Brian Drachman, David Steidley, Scott Hummel, David Slosky, Hector Ventura, Daniel Jacoby, James Hoffman, James Tauras, Sasa Zivkovic, Jose Tallaj, Daniel Lenihan, and Christopher Mueller
- Subjects
Pathology ,medicine.medical_specialty ,Registry ,wild-type transthyretin amyloidosis ,ATTR-CM, transthyretin amyloid cardiomyopathy ,ATTRv amyloidosis, variant transthyretin amyloidosis ,macromolecular substances ,registry ,NO ,mental disorders ,medicine ,bone scintigraphy ,NYHA, New York Heart Association ,Original Research ,TTR, transthyretin ,biology ,business.industry ,Amyloidosis ,ATTRwt amyloidosis, wild-type transthyretin amyloidosis ,Wild type ,nutritional and metabolic diseases ,medicine.disease ,Amyloid fibril ,nervous system diseases ,Transthyretin ,Wild-type transthyretin amyloidosis ,Oncology ,ATTR amyloidosis, transthyretin amyloidosis ,biology.protein ,Cardiology and Cardiovascular Medicine ,business ,Amyloid cardiomyopathy ,Bone scintigraphy ,Q, quartile - Abstract
Background Transthyretin amyloid cardiomyopathy results from the accumulation of wild-type (ATTRwt) or variant (ATTRv) transthyretin amyloid fibrils in the myocardium. THAOS (Transthyretin Amyloidosis Outcomes Survey) is a global, longitudinal, observational survey of patients with ATTRv and ATTRwt amyloidosis and asymptomatic patients with transthyretin mutations. Objectives This study explored temporal trends in ATTRwt amyloidosis diagnoses using data from THAOS. Methods Using THAOS data from December 2007 to January 2020, the following comparisons were made according to year: ATTRwt amyloidosis diagnoses in the United States versus rest of the world, ATTRwt versus ATTRv amyloidosis with cardiac-associated mutations diagnoses, and ATTRwt amyloidosis diagnoses by tissue biopsy versus bone scintigraphy. Results There were 1,069 patients with ATTRwt amyloidosis and 525 with ATTRv amyloidosis with cardiac mutations enrolled in THAOS. The median time from symptom onset to ATTRwt amyloidosis diagnosis did not change over the past 5 years (>60 months from 2015–2019). ATTRwt amyloidosis diagnoses increased from 2 in 2005 to >100 per year from 2016, with a more pronounced increase in the United States compared with the rest of the world. Diagnoses of ATTRwt amyloidosis by tissue biopsy increased yearly and peaked in 2014 before declining, whereas diagnoses by bone scintigraphy increased markedly since 2011. ATTRv amyloidosis with cardiac mutation diagnoses increased from 3 in 2005 to 37 in 2011, then plateaued. The proportion of patients with ATTRwt amyloidosis diagnosed with New York Heart Association functional class III/IV heart failure decreased from 2012 (46.4%) to 2019 (16.0%). Conclusions In the past decade, ATTRwt amyloidosis diagnoses increased worldwide. Despite the growing utilization of bone scintigraphy, patients are diagnosed several years after symptom onset. (Transthyretin Amyloidosis Outcomes Survey [THAOS]; NCT00628745), Central Illustration
- Published
- 2022
42. Spatial concordance of DNA methylation classification in diffuse glioma
- Author
-
Philip C. De Witt Hamer, Petra J. W. Pouwels, W Pieter Vandertop, Frederik Barkhof, Otto S. Hoekstra, Kevin J. Anderson, Sunit Das, Annemieke J.M. Rozemuller, Niels Verburg, Pieter Wesseling, Ronald Boellaard, Michael D. Taylor, Jeroen A.M. Beliën, Jaap C. Reijneveld, Roel G.W. Verhaak, Maqsood Yaqub, Joseph F. Costello, Kevin C. Johnson, Adriaan A. Lammertsma, Floris P. Barthel, Thomas Koopman, Neurosurgery, Radiology and nuclear medicine, Amsterdam Neuroscience - Brain Imaging, CCA - Imaging and biomarkers, AMS - Tissue Function & Regeneration, Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep, Amsterdam Neuroscience - Neuroinfection & -inflammation, Neurology, Amsterdam Neuroscience - Neurodegeneration, Pathology, Amsterdam Neuroscience - Neurovascular Disorders, Amsterdam Neuroscience - Systems & Network Neuroscience, CCA - Cancer Treatment and Quality of Life, ANS - Neurovascular Disorders, and ANS - Systems & Network Neuroscience
- Subjects
Adult ,0301 basic medicine ,DNA methylation classification ,Cancer Research ,Oligodendroglioma ,Intratumoral heterogeneity ,Biology ,Imaging ,03 medical and health sciences ,Diffuse Glioma ,0302 clinical medicine ,Diffuse Astrocytoma ,glioma ,Glioma ,medicine ,Humans ,AcademicSubjects/MED00300 ,Epigenetics ,epigenetics ,Brain Neoplasms ,Genetic heterogeneity ,imaging ,Methylation ,DNA Methylation ,medicine.disease ,Isocitrate Dehydrogenase ,030104 developmental biology ,Oncology ,Mutation ,Basic and Translational Investigations ,intratumoral heterogeneity ,DNA methylation ,Cancer research ,AcademicSubjects/MED00310 ,Neurology (clinical) ,030217 neurology & neurosurgery - Abstract
Background Intratumoral heterogeneity is a hallmark of diffuse gliomas. DNA methylation profiling is an emerging approach in the clinical classification of brain tumors. The goal of this study is to investigate the effects of intratumoral heterogeneity on classification confidence. Methods We used neuronavigation to acquire 133 image-guided and spatially separated stereotactic biopsy samples from 16 adult patients with a diffuse glioma (7 IDH-wildtype and 2 IDH-mutant glioblastoma, 6 diffuse astrocytoma, IDH-mutant and 1 oligodendroglioma, IDH-mutant and 1p19q codeleted), which we characterized using DNA methylation arrays. Samples were obtained from regions with and without abnormalities on contrast-enhanced T1-weighted and fluid-attenuated inversion recovery MRI. Methylation profiles were analyzed to devise a 3-dimensional reconstruction of (epi)genetic heterogeneity. Tumor purity was assessed from clonal methylation sites. Results Molecular aberrations indicated that tumor was found outside imaging abnormalities, underlining the infiltrative nature of this tumor and the limitations of current routine imaging modalities. We demonstrate that tumor purity is highly variable between samples and explains a substantial part of apparent epigenetic spatial heterogeneity. We observed that DNA methylation subtypes are often, but not always, conserved in space taking tumor purity and prediction accuracy into account. Conclusion Our results underscore the infiltrative nature of diffuse gliomas and suggest that DNA methylation subtypes are relatively concordant in this tumor type, although some heterogeneity exists.
- Published
- 2021
- Full Text
- View/download PDF
43. The contribution of single-cell analysis of acute leukemia in the therapeutic strategy
- Author
-
Laure Farnault, Béatrice Loriod, Geoffroy Venton, Julien Colle, Régis T. Costello, Lamia Madaci, Theories and Approaches of Genomic Complexity (TAGC), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Transscriptomics and Genomics of Marseille-Luminy (TGML), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Spinelli, Lionel
- Subjects
0301 basic medicine ,Tumor heterogeneity ,Acute myeloblastic leukemia ,medicine.medical_treatment ,Clinical Biochemistry ,Leukemia stem cell ,Review ,RM1-950 ,Biology ,Somatic evolution in cancer ,Targeted therapy ,03 medical and health sciences ,0302 clinical medicine ,Single-cell analysis ,Next generation sequencing ,medicine ,Single cell ,Acute leukemia ,Clonal evolution ,Acute myeloid leukemia ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,Biochemistry (medical) ,Immunotherapy ,medicine.disease ,3. Good health ,Leukemia ,030104 developmental biology ,Tumor Escape ,030220 oncology & carcinogenesis ,Drug resistance ,Cancer research ,Molecular Medicine ,Therapeutics. Pharmacology ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
After decades during which the treatment of acute myeloblastic leukemia was limited to variations around a skeleton of cytarabine/anthracycline, targeted therapies appeared. These therapies, first based on monoclonal antibodies, also rely on specific inhibitors of various molecular abnormalities. A significant but modest prognosis improvement has been observed thanks to these new treatments that are limited by a high rate of relapse, due to the intrinsic chemo and immune-resistance of leukemia stem cell, together with the acquisition of these resistances by clonal evolution. Relapses are also influenced by the equilibrium between the pro or anti-tumor signals from the bone marrow stromal microenvironment and immune effectors. What should be the place of the targeted therapeutic options in light of the tumor heterogeneity inherent to leukemia and the clonal drift of which this type of tumor is capable? Novel approaches by single cell analysis and next generation sequencing precisely define clonal heterogeneity and evolution, leading to a personalized and time variable adapted treatment. Indeed, the evolution of leukemia, either spontaneous or under therapy selection pressure, is a very complex phenomenon. The model of linear evolution is to be forgotten because single cell analysis of samples at diagnosis and at relapse show that tumor escape to therapy occurs from ancestral as well as terminal clones. The determination by the single cell technique of the trajectories of the different tumor sub-populations allows the identification of clones that accumulate factors of resistance to chemo/immunotherapy (“pan-resistant clones”), making possible to choose the combinatorial agents most likely to eradicate these cells. In addition, the single cell technique identifies the nature of each cell and can analyze, on the same sample, both the tumor cells and their environment. It is thus possible to evaluate the populations of immune effectors (T-lymphocytes, natural killer cells) for the leukemia stress-induced alteration of their functions. Finally, the single cells techniques are an invaluable tool for evaluation of the measurable residual disease since not only able to quantify but also to determine the most appropriate treatment according to the sensitivity profile to immuno-chemotherapy of remaining leukemic cells.
- Published
- 2021
- Full Text
- View/download PDF
44. National Retail Sales of Alcohol and Cannabis During the COVID-19 Pandemic in Canada
- Author
-
Alysha Cooper, James MacKillop, and Jean Costello
- Subjects
2019-20 coronavirus outbreak ,Canada ,Coronavirus disease 2019 (COVID-19) ,Alcohol Drinking ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Marijuana use ,Retail sales ,Political science ,Environmental health ,Pandemic ,Research Letter ,Humans ,Pandemics ,health care economics and organizations ,Cannabis ,Psychiatry ,biology ,SARS-CoV-2 ,Alcoholic Beverages ,Research ,technology, industry, and agriculture ,Commerce ,food and beverages ,COVID-19 ,General Medicine ,biology.organism_classification ,Online Only ,Marijuana Use - Abstract
This economic evaluation examines national retail sales of alcohol and cannabis before and during the COVID-19 pandemic in Canada.
- Published
- 2021
45. The effect of ultrasound treatment in combination with nisin on the inactivation of Listeria innocua and Escherichia coli
- Author
-
Katherine M. Costello, Cindy Smet, Eirini Velliou, Jan Van Impe, Jorge Gutierrez-Merino, Madeleine Bussemaker, and Hani El Kadri
- Subjects
Technology ,Acoustics and Ultrasonics ,Chemistry, Multidisciplinary ,Colony Count, Microbial ,Hurdle technology ,medicine.disease_cause ,CAVITATION THRESHOLD ,Inactivation ,chemistry.chemical_compound ,HIGH-INTENSITY ULTRASOUND ,polycyclic compounds ,innocua ,Chemical Engineering (miscellaneous) ,Food science ,Original Research Article ,Nisin ,NONTHERMAL TECHNOLOGIES ,biology ,FLOW-CYTOMETRY ,food and beverages ,Anti-Bacterial Agents ,Chemistry ,Physical Sciences ,lipids (amino acids, peptides, and proteins) ,Bacterial outer membrane ,medicine.drug ,POWER ULTRASOUND ,Listeria ,Sonication ,ANTIMICROBIAL SUSCEPTIBILITY ,QC221-246 ,Inorganic Chemistry ,MONOCYTOGENES SCOTT-A ,Ultrasound ,medicine ,Escherichia coli ,Environmental Chemistry ,Radiology, Nuclear Medicine and imaging ,QD1-999 ,STAPHYLOCOCCUS-AUREUS ,INERTIAL CAVITATION ,Science & Technology ,Organic Chemistry ,Acoustics. Sound ,E. coli ,Acoustics ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,STAINLESS-STEEL ,coli ,chemistry ,L. innocua ,bacteria ,Bacteria ,Xanthan gum - Abstract
Highlights • A multi-frequency study of ultrasound (US) and nisin for microbial inactivation. • US impacts E. coli at 500 kHz only; L. innocua resists all frequencies studied. • Nisin applied before US enhances inactivation of E. coli but not when applied after. • Attributed to outer membrane destabilisation by US allowing nisin penetration. • System structure (viscosity) reduces US inactivation efficacy., Ultrasound, alone or in combination with natural antimicrobials, is a novel food processing technology of interest to replace traditional food decontamination methods, as it is milder than classical sterilisation (heat treatment) and maintains desirable sensory characteristics. However, ultrasound efficacy can be affected by food structure/composition, as well as the order in which combined treatments are applied. More specifically, treatments which target different cell components could result in enhanced inactivation if applied in the appropriate order. The microbial properties i.e. Gram positive/Gram negative can also impact the treatment efficacy. This work presents a systematic study of the combined effect of ultrasound and nisin on the inactivation of the bacteria Listeria innocua (Gram positive) and Escherichia coli (Gram negative), at a range of cavitation conditions (44, 500, 1000 kHz). The order of treatment application was varied, and the impact of system structure was also investigated by varying the concentration of Xanthan gum used to create the food model systems (0 – 0.5% w/v). Microbial inactivation kinetics were monitored, and advanced microscopy and flow cytometry techniques were utilised to quantify the impact of treatment on a cellular level. Ultrasound was shown to be effective against E. coli at 500 kHz only, with L. innocua demonstrating resistance to all frequencies studied. Enhanced inactivation of E. coli was observed for the combination of nisin and ultrasound at 500 kHz, but only when nisin was applied before ultrasound treatment. The system structure negatively impacted the inactivation efficacy. The combined effect of ultrasound and nisin on E. coli was attributed to short-lived destabilisation of the outer membrane as a result of sonication, allowing nisin to penetrate the cytoplasmic membrane and facilitate cell inactivation.
- Published
- 2021
46. Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk
- Author
-
Raffaele Pezzilli, Pavel Vodicka, Andrea Párniczky, George Theodoropoulos, Renata Talar-Wojnarowska, Paolo Giorgio Arcidiacono, Ugo Boggi, Bálint Erőss, Ewa Małecka-Panas, Martin Oliverius, Daniele Campa, Rita T. Lawlor, Faik G. Uzunoglu, Maria Chiara Petrone, Livia Archibugi, Stefania Bunduc, Edita Kreivenaite, Beatrice Mohelnikova-Duchonova, Manuel Gentiluomo, Maria Liliana Piredda, Giulia Peduzzi, Thilo Hackert, Francesco Perri, Giuseppe Vanella, Olivier R. Busch, Hermann Brenner, Pavel Soucek, John P. Neoptolemos, Martin Schneider, Sabrina Gloria Giulia Testoni, Luca Morelli, Krzysztof Jamroziak, Federico Canzian, Daniela Basso, Silvia Carrara, Maria Gazouli, Juozas Kupcinskas, Konstantinos Georgiou, Xīn Gào, Claudio Pasquali, Cosimo Sperti, Evaristo Maiello, Vytautas Kiudelis, Mara Götz, Martin Loos, Gabriele Capurso, Francesca Bazzocchi, Martin Lovecek, Bas Bueno-de-Mesquita, Viktor Hlavac, Niccola Funel, Roel Vermeulen, Maarten F. Bijlsma, Anna Caterina Milanetto, Ye Lu, Giulia Martina Cavestro, Stefano Ermini, Andrea Szentesi, Jakob R. Izbicki, William Greenhalf, Francesca Tavano, Feng Guo, Marta Puzzono, Domenica Gioffreda, Péter Hegyi, Eithne Costello, Casper H.J. van Eijck, Stefano Landi, Peduzzi, G., Gentiluomo, M., Tavano, F., Arcidiacono, P. G., Ermini, S., Vodicka, P., Boggi, U., Cavestro, G. M., Capurso, G., Morelli, L., Milanetto, A. C., Pezzilli, R., Lawlor, R. T., Carrara, S., Lovecek, M., Soucek, P., Guo, F., Hackert, T., Uzunoglu, F. G., Gazouli, M., Parniczky, A., Kupcinskas, J., Bijlsma, M. F., Bueno-De-Mesquita, B., Vermeulen, R., van Eijck, C. H. J., Jamroziak, K., Talar-Wojnarowska, R., Greenhalf, W., Gioffreda, D., Petrone, M. C., Landi, S., Archibugi, L., Puzzono, M., Funel, N., Sperti, C., Piredda, M. L., Mohelnikova-Duchonova, B., Lu, Y., Hlavac, V., Gao, X., Schneider, M., Izbicki, J. R., Theodoropoulos, G., Bunduc, S., Kreivenaite, E., Busch, O. R., Malecka-Panas, E., Costello, E., Perri, F., Giulia Testoni, S. G., Vanella, G., Pasquali, C., Oliverius, M., Brenner, H., Loos, M., Gotz, M., Georgiou, K., Eross, B., Maiello, E., Szentesi, A., Bazzocchi, F., Basso, D., Neoptolemos, J. P., Hegyi, P., Kiudelis, V., Canzian, F., Campa, D., Surgery, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, Center of Experimental and Molecular Medicine, and AGEM - Amsterdam Gastroenterology Endocrinology Metabolism
- Subjects
Mitochondrial DNA ,Pancreatic ductal adenocarcinoma ,Nuclear gene ,endocrine system diseases ,Epidemiology ,Biology ,SUSCEPTIBILITY ,Polymorphism, Single Nucleotide ,SDG 3 - Good Health and Well-being ,Pancreatic cancer ,medicine ,Humans ,03.02. Klinikai orvostan ,Genetic variability ,Carcinoma, Pancreatic Ductal ,Case-Control Studies ,Genetic Variation ,Genome, Mitochondrial ,Mitochondria ,Pancreatic Neoplasms ,Polymorphism ,GENOME-WIDE ASSOCIATION ,Gene ,Genetics ,Genome ,GENOME-WIDE ASSOCIATION, SUSCEPTIBILITY ,Carcinoma ,Single Nucleotide ,Metabolism ,medicine.disease ,digestive system diseases ,Mitochondrial ,Oncology ,Pancreatic Ductal - Abstract
Background: The mitochondrial metabolism has been associated with pancreatic ductal adenocarcinoma (PDAC) risk. Recent evidence also suggests the involvement of the genetic variability of the mitochondrial function in several traits involved in PDAC etiology. However, a systematic investigation of the genetic variability of mitochondrial genome (mtSNP) and of all the nuclear genes involved in its functioning (n-mtSNPs) has never been reported. Methods: We conducted a two-phase association study of mtSNPs and n-mtSNPs to assess their effect on PDAC risk. We analyzed 35,297 n-mtSNPs and 101 mtSNPs in up to 55,870 individuals (12,884 PDAC cases and 42,986 controls). In addition, we also conducted a gene-based analysis on 1,588 genes involved in mitochondrial metabolism using Multi-marker Analysis of GenoMic Annotation (MAGMA) software. Results: In the discovery phase, we identified 49 n-mtSNPs and no mtSNPs associated with PDAC risk (P < 0.05). In the second phase, none of the findings were replicated. In the gene-level analysis, we observed that three genes (TERT, SUGCT, and SURF1) involved in the mitochondrial metabolism showed an association below the Bonferroni-corrected threshold of statistical significance (P = 0.05/1588 = 3.1 × 10−5). Conclusions: Even though the mitochondrial metabolism might be involved in PDAC etiology, our results, obtained in a study with one of the largest sample sizes to date, show that neither n-mtSNPs nor mtSNPs are associated with PDAC risk. Impact: This large case–control study does not support a role of the genetic variability of the mitochondrial function in PDAC risk.
- Published
- 2021
47. Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival
- Author
-
Chiara Corradi, Carsten Palnæs Hansen, Beatrice Mohelnikova-Duchonova, Maria Gazouli, Francesca Tavano, Paolo Giorgio Arcidiacono, Anna Caterina Milanetto, Pavel Soucek, Gabriele Capurso, Casper H.J. van Eijck, Dania Bozzato, Oliver Strobel, Federico Canzian, Thilo Hackert, Manuel Gentiluomo, Giuseppe Vanella, Erika Darvasi, Giulia Martina Cavestro, Andrea Szentesi, Juozas Kupcinskas, John P. Neoptolemos, Astrid Z. Johansen, Raffaele Pezzilli, Pavel Vodicka, Péter Hegyi, Eithne Costello, Renata Talar-Wojnarowska, Daniele Campa, Liliana Piredda, Julia S. Johansen, Inna Chen, Gentiluomo, M., Corradi, C., Vanella, G., Johansen, A. Z., Strobel, O., Szentesi, A., Milanetto, A. C., Hegyi, P., Kupcinskas, J., Tavano, F., Neoptolemos, J. P., Bozzato, D., Hackert, T., Pezzilli, R., Johansen, J. S., Costello, E., Mohelnikova-Duchonova, B., van Eijck, C. H. J., Talar-Wojnarowska, R., Hansen, C. P., Darvasi, E., Chen, I. M., Cavestro, G. M., Soucek, P., Piredda, L., Vodicka, P., Gazouli, M., Arcidiacono, P. G., Canzian, F., Campa, D., Capurso, G., and Surgery
- Subjects
Oncology ,Male ,medicine.medical_specialty ,Pancreatic disease ,Pancreatic ductal adenocarcinoma ,Science ,Disease ,Kaplan-Meier Estimate ,Polymorphism, Single Nucleotide ,Article ,Gastrointestinal cancer ,Cancer epidemiology ,Internal medicine ,Genotype ,Biomarkers, Tumor ,Cancer genomics ,Aged ,Carcinoma, Pancreatic Ductal ,Chitinases ,Female ,Humans ,Hyaluronan Receptors ,Middle Aged ,Pancreatic Neoplasms ,Medicine ,In patient ,Polymorphism ,Stage (cooking) ,Cancer genetics ,Tumor ,Multidisciplinary ,biology ,business.industry ,Carcinoma ,CD44 ,Single Nucleotide ,medicine.disease ,Pancreatic Ductal ,Genetic marker ,biology.protein ,business ,Biomarkers - Abstract
Although pancreatic ductal adenocarcinoma (PDAC) survival is poor, there are differences in patients’ response to the treatments. Detection of predictive biomarkers explaining these differences is of the utmost importance. In a recent study two genetic markers (CD44-rs353630 and CHI3L2-rs684559) were reported to be associated with survival after PDAC resection. We attempted to replicate the associations in 1856 PDAC patients (685 resected with stage I/II) from the PANcreatic Disease ReseArch (PANDoRA) consortium. We also analysed the combined effect of the two genotypes in order to compare our results with what was previously reported. Additional stratified analyses considering TNM stage of the disease and whether the patients received surgery were also performed. We observed no statistically significant associations, except for the heterozygous carriers of CD44-rs353630, who were associated with worse OS (HR = 5.01; 95% CI 1.58–15.88; p = 0.006) among patients with stage I disease. This association is in the opposite direction of those reported previously, suggesting that data obtained in such small subgroups are hardly replicable and should be considered cautiously. The two polymorphisms combined did not show any statistically significant association. Our results suggest that the effect of CD44-rs353630 and CHI3L2-rs684559 cannot be generalized to all PDAC patients.
- Published
- 2021
- Full Text
- View/download PDF
48. The T-box transcription factor Eomesodermin governs haemogenic competence of yolk sac mesodermal progenitors
- Author
-
Claire S. Simon, Lucas Greder, Elizabeth J. Robertson, Anna D. Senft, Ivan Imaz-Rosshandler, Catherine Porcher, Luke T. G. Harland, Marella F. T. R. de Bruijn, John C. Marioni, Berthold Göttgens, Elizabeth K. Bikoff, Ita Costello, Simon, Claire S [0000-0001-9614-1403], Senft, Anna D [0000-0001-9351-9132], Costello, Ita [0000-0002-6770-3769], Göttgens, Berthold [0000-0001-6302-5705], Marioni, John C [0000-0001-9092-0852], Porcher, Catherine [0000-0002-9015-5203], de Bruijn, Marella FTR [0000-0002-4934-4125], Robertson, Elizabeth J [0000-0001-6562-0225], and Apollo - University of Cambridge Repository
- Subjects
Male ,Mesoderm ,Hemangioblasts ,Eomesodermin ,Biology ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Pregnancy ,medicine ,Animals ,RNA-Seq ,Yolk sac ,Transcription factor ,Embryonic Stem Cells ,T-Cell Acute Lymphocytic Leukemia Protein 1 ,030304 developmental biology ,Yolk Sac ,Mice, Knockout ,0303 health sciences ,Cell Biology ,Embryonic stem cell ,Vascular Endothelial Growth Factor Receptor-2 ,Cell biology ,Haematopoiesis ,medicine.anatomical_structure ,T-box ,RUNX1 ,chemistry ,030220 oncology & carcinogenesis ,embryonic structures ,Core Binding Factor Alpha 2 Subunit ,Female ,Single-Cell Analysis ,T-Box Domain Proteins - Abstract
Extra-embryonic mesoderm (ExM)-composed of the earliest cells that traverse the primitive streak-gives rise to the endothelium as well as haematopoietic progenitors in the developing yolk sac. How a specific subset of ExM becomes committed to a haematopoietic fate remains unclear. Here we demonstrate using an embryonic stem cell model that transient expression of the T-box transcription factor Eomesodermin (Eomes) governs haemogenic competency of ExM. Eomes regulates the accessibility of enhancers that the transcription factor stem cell leukaemia (SCL) normally utilizes to specify primitive erythrocytes and is essential for the normal development of Runx1+ haemogenic endothelium. Single-cell RNA sequencing suggests that Eomes loss of function profoundly blocks the formation of blood progenitors but not specification of Flk-1+ haematoendothelial progenitors. Our findings place Eomes at the top of the transcriptional hierarchy regulating early blood formation and suggest that haemogenic competence is endowed earlier during embryonic development than was previously appreciated.
- Published
- 2020
- Full Text
- View/download PDF
49. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
- Author
-
Gregory P. Way, Francisco Sanchez-Vega, Konnor La, Joshua Armenia, Walid K. Chatila, Augustin Luna, Chris Sander, Andrew D. Cherniack, Marco Mina, Giovanni Ciriello, Nikolaus Schultz, Yolanda Sanchez, Casey S. Greene, Samantha J. Caesar-Johnson, John A. Demchok, Ina Felau, Melpomeni Kasapi, Martin L. Ferguson, Carolyn M. Hutter, Heidi J. Sofia, Roy Tarnuzzer, Zhining Wang, Liming Yang, Jean C. Zenklusen, Jiashan (Julia) Zhang, Sudha Chudamani, Jia Liu, Laxmi Lolla, Rashi Naresh, Todd Pihl, Qiang Sun, Yunhu Wan, Ye Wu, Juok Cho, Timothy DeFreitas, Scott Frazer, Nils Gehlenborg, Gad Getz, David I. Heiman, Jaegil Kim, Michael S. Lawrence, Pei Lin, Sam Meier, Michael S. Noble, Gordon Saksena, Doug Voet, Hailei Zhang, Brady Bernard, Nyasha Chambwe, Varsha Dhankani, Theo Knijnenburg, Roger Kramer, Kalle Leinonen, Yuexin Liu, Michael Miller, Sheila Reynolds, Ilya Shmulevich, Vesteinn Thorsson, Wei Zhang, Rehan Akbani, Bradley M. Broom, Apurva M. Hegde, Zhenlin Ju, Rupa S. Kanchi, Anil Korkut, Jun Li, Han Liang, Shiyun Ling, Wenbin Liu, Yiling Lu, Gordon B. Mills, Kwok-Shing Ng, Arvind Rao, Michael Ryan, Jing Wang, John N. Weinstein, Jiexin Zhang, Adam Abeshouse, Debyani Chakravarty, Ino de Bruijn, Jianjiong Gao, Benjamin E. Gross, Zachary J. Heins, Ritika Kundra, Marc Ladanyi, Moriah G. Nissan, Angelica Ochoa, Sarah M. Phillips, Ed Reznik, Robert Sheridan, S. Onur Sumer, Yichao Sun, Barry S. Taylor, Jioajiao Wang, Hongxin Zhang, Pavana Anur, Myron Peto, Paul Spellman, Christopher Benz, Joshua M. Stuart, Christopher K. Wong, Christina Yau, D. Neil Hayes, Joel S. Parker, Matthew D. Wilkerson, Adrian Ally, Miruna Balasundaram, Reanne Bowlby, Denise Brooks, Rebecca Carlsen, Eric Chuah, Noreen Dhalla, Robert Holt, Steven J.M. Jones, Katayoon Kasaian, Darlene Lee, Yussanne Ma, Marco A. Marra, Michael Mayo, Richard A. Moore, Andrew J. Mungall, Karen Mungall, A. Gordon Robertson, Sara Sadeghi, Jacqueline E. Schein, Payal Sipahimalani, Angela Tam, Nina Thiessen, Kane Tse, Tina Wong, Ashton C. Berger, Rameen Beroukhim, Carrie Cibulskis, Stacey B. Gabriel, Galen F. Gao, Gavin Ha, Matthew Meyerson, Steven E. Schumacher, Juliann Shih, Melanie H. Kucherlapati, Raju S. Kucherlapati, Stephen Baylin, Leslie Cope, Ludmila Danilova, Moiz S. Bootwalla, Phillip H. Lai, Dennis T. Maglinte, David J. Van Den Berg, Daniel J. Weisenberger, J. Todd Auman, Saianand Balu, Tom Bodenheimer, Cheng Fan, Katherine A. Hoadley, Alan P. Hoyle, Stuart R. Jefferys, Corbin D. Jones, Shaowu Meng, Piotr A. Mieczkowski, Lisle E. Mose, Amy H. Perou, Charles M. Perou, Jeffrey Roach, Yan Shi, Janae V. Simons, Tara Skelly, Matthew G. Soloway, Donghui Tan, Umadevi Veluvolu, Huihui Fan, Toshinori Hinoue, Peter W. Laird, Hui Shen, Wanding Zhou, Michelle Bellair, Kyle Chang, Kyle Covington, Chad J. Creighton, Huyen Dinh, HarshaVardhan Doddapaneni, Lawrence A. Donehower, Jennifer Drummond, Richard A. Gibbs, Robert Glenn, Walker Hale, Yi Han, Jianhong Hu, Viktoriya Korchina, Sandra Lee, Lora Lewis, Wei Li, Xiuping Liu, Margaret Morgan, Donna Morton, Donna Muzny, Jireh Santibanez, Margi Sheth, Eve Shinbrot, Linghua Wang, Min Wang, David A. Wheeler, Liu Xi, Fengmei Zhao, Julian Hess, Elizabeth L. Appelbaum, Matthew Bailey, Matthew G. Cordes, Li Ding, Catrina C. Fronick, Lucinda A. Fulton, Robert S. Fulton, Cyriac Kandoth, Elaine R. Mardis, Michael D. McLellan, Christopher A. Miller, Heather K. Schmidt, Richard K. Wilson, Daniel Crain, Erin Curley, Johanna Gardner, Kevin Lau, David Mallery, Scott Morris, Joseph Paulauskis, Robert Penny, Candace Shelton, Troy Shelton, Mark Sherman, Eric Thompson, Peggy Yena, Jay Bowen, Julie M. Gastier-Foster, Mark Gerken, Kristen M. Leraas, Tara M. Lichtenberg, Nilsa C. Ramirez, Lisa Wise, Erik Zmuda, Niall Corcoran, Tony Costello, Christopher Hovens, Andre L. Carvalho, Ana C. de Carvalho, José H. Fregnani, Adhemar Longatto-Filho, Rui M. Reis, Cristovam Scapulatempo-Neto, Henrique C.S. Silveira, Daniel O. Vidal, Andrew Burnette, Jennifer Eschbacher, Beth Hermes, Ardene Noss, Rosy Singh, Matthew L. Anderson, Patricia D. Castro, Michael Ittmann, David Huntsman, Bernard Kohl, Xuan Le, Richard Thorp, Chris Andry, Elizabeth R. Duffy, Vladimir Lyadov, Oxana Paklina, Galiya Setdikova, Alexey Shabunin, Mikhail Tavobilov, Christopher McPherson, Ronald Warnick, Ross Berkowitz, Daniel Cramer, Colleen Feltmate, Neil Horowitz, Adam Kibel, Michael Muto, Chandrajit P. Raut, Andrei Malykh, Jill S. Barnholtz-Sloan, Wendi Barrett, Karen Devine, Jordonna Fulop, Quinn T. Ostrom, Kristen Shimmel, Yingli Wolinsky, Andrew E. Sloan, Agostino De Rose, Felice Giuliante, Marc Goodman, Beth Y. Karlan, Curt H. Hagedorn, John Eckman, Jodi Harr, Jerome Myers, Kelinda Tucker, Leigh Anne Zach, Brenda Deyarmin, Hai Hu, Leonid Kvecher, Caroline Larson, Richard J. Mural, Stella Somiari, Ales Vicha, Tomas Zelinka, Joseph Bennett, Mary Iacocca, Brenda Rabeno, Patricia Swanson, Mathieu Latour, Louis Lacombe, Bernard Têtu, Alain Bergeron, Mary McGraw, Susan M. Staugaitis, John Chabot, Hanina Hibshoosh, Antonia Sepulveda, Tao Su, Timothy Wang, Olga Potapova, Olga Voronina, Laurence Desjardins, Odette Mariani, Sergio Roman-Roman, Xavier Sastre, Marc-Henri Stern, Feixiong Cheng, Sabina Signoretti, Andrew Berchuck, Darell Bigner, Eric Lipp, Jeffrey Marks, Shannon McCall, Roger McLendon, Angeles Secord, Alexis Sharp, Madhusmita Behera, Daniel J. Brat, Amy Chen, Keith Delman, Seth Force, Fadlo Khuri, Kelly Magliocca, Shishir Maithel, Jeffrey J. Olson, Taofeek Owonikoko, Alan Pickens, Suresh Ramalingam, Dong M. Shin, Gabriel Sica, Erwin G. Van Meir, Hongzheng Zhang, Wil Eijckenboom, Ad Gillis, Esther Korpershoek, Leendert Looijenga, Wolter Oosterhuis, Hans Stoop, Kim E. van Kessel, Ellen C. Zwarthoff, Chiara Calatozzolo, Lucia Cuppini, Stefania Cuzzubbo, Francesco DiMeco, Gaetano Finocchiaro, Luca Mattei, Alessandro Perin, Bianca Pollo, Chu Chen, John Houck, Pawadee Lohavanichbutr, Arndt Hartmann, Christine Stoehr, Robert Stoehr, Helge Taubert, Sven Wach, Bernd Wullich, Witold Kycler, Dawid Murawa, Maciej Wiznerowicz, Ki Chung, W. Jeffrey Edenfield, Julie Martin, Eric Baudin, Glenn Bubley, Raphael Bueno, Assunta De Rienzo, William G. Richards, Steven Kalkanis, Tom Mikkelsen, Houtan Noushmehr, Lisa Scarpace, Nicolas Girard, Marta Aymerich, Elias Campo, Eva Giné, Armando López Guillermo, Nguyen Van Bang, Phan Thi Hanh, Bui Duc Phu, Yufang Tang, Howard Colman, Kimberley Evason, Peter R. Dottino, John A. Martignetti, Hani Gabra, Hartmut Juhl, Teniola Akeredolu, Serghei Stepa, Dave Hoon, Keunsoo Ahn, Koo Jeong Kang, Felix Beuschlein, Anne Breggia, Michael Birrer, Debra Bell, Mitesh Borad, Alan H. Bryce, Erik Castle, Vishal Chandan, John Cheville, John A. Copland, Michael Farnell, Thomas Flotte, Nasra Giama, Thai Ho, Michael Kendrick, Jean-Pierre Kocher, Karla Kopp, Catherine Moser, David Nagorney, Daniel O’Brien, Brian Patrick O’Neill, Tushar Patel, Gloria Petersen, Florencia Que, Michael Rivera, Lewis Roberts, Robert Smallridge, Thomas Smyrk, Melissa Stanton, R. Houston Thompson, Michael Torbenson, Ju Dong Yang, Lizhi Zhang, Fadi Brimo, Jaffer A. Ajani, Ana Maria Angulo Gonzalez, Carmen Behrens, Jolanta Bondaruk, Russell Broaddus, Bogdan Czerniak, Bita Esmaeli, Junya Fujimoto, Jeffrey Gershenwald, Charles Guo, Alexander J. Lazar, Christopher Logothetis, Funda Meric-Bernstam, Cesar Moran, Lois Ramondetta, David Rice, Anil Sood, Pheroze Tamboli, Timothy Thompson, Patricia Troncoso, Anne Tsao, Ignacio Wistuba, Candace Carter, Lauren Haydu, Peter Hersey, Valerie Jakrot, Hojabr Kakavand, Richard Kefford, Kenneth Lee, Georgina Long, Graham Mann, Michael Quinn, Robyn Saw, Richard Scolyer, Kerwin Shannon, Andrew Spillane, Jonathan Stretch, Maria Synott, John Thompson, James Wilmott, Hikmat Al-Ahmadie, Timothy A. Chan, Ronald Ghossein, Anuradha Gopalan, Douglas A. Levine, Victor Reuter, Samuel Singer, Bhuvanesh Singh, Nguyen Viet Tien, Thomas Broudy, Cyrus Mirsaidi, Praveen Nair, Paul Drwiega, Judy Miller, Jennifer Smith, Howard Zaren, Joong-Won Park, Nguyen Phi Hung, Electron Kebebew, W. Marston Linehan, Adam R. Metwalli, Karel Pacak, Peter A. Pinto, Mark Schiffman, Laura S. Schmidt, Cathy D. Vocke, Nicolas Wentzensen, Robert Worrell, Hannah Yang, Marc Moncrieff, Chandra Goparaju, Jonathan Melamed, Harvey Pass, Natalia Botnariuc, Irina Caraman, Mircea Cernat, Inga Chemencedji, Adrian Clipca, Serghei Doruc, Ghenadie Gorincioi, Sergiu Mura, Maria Pirtac, Irina Stancul, Diana Tcaciuc, Monique Albert, Iakovina Alexopoulou, Angel Arnaout, John Bartlett, Jay Engel, Sebastien Gilbert, Jeremy Parfitt, Harman Sekhon, George Thomas, Doris M. Rassl, Robert C. Rintoul, Carlo Bifulco, Raina Tamakawa, Walter Urba, Nicholas Hayward, Henri Timmers, Anna Antenucci, Francesco Facciolo, Gianluca Grazi, Mirella Marino, Roberta Merola, Ronald de Krijger, Anne-Paule Gimenez-Roqueplo, Alain Piché, Simone Chevalier, Ginette McKercher, Kivanc Birsoy, Gene Barnett, Cathy Brewer, Carol Farver, Theresa Naska, Nathan A. Pennell, Daniel Raymond, Cathy Schilero, Kathy Smolenski, Felicia Williams, Carl Morrison, Jeffrey A. Borgia, Michael J. Liptay, Mark Pool, Christopher W. Seder, Kerstin Junker, Larsson Omberg, Mikhail Dinkin, George Manikhas, Domenico Alvaro, Maria Consiglia Bragazzi, Vincenzo Cardinale, Guido Carpino, Eugenio Gaudio, David Chesla, Sandra Cottingham, Michael Dubina, Fedor Moiseenko, Renumathy Dhanasekaran, Karl-Friedrich Becker, Klaus-Peter Janssen, Julia Slotta-Huspenina, Mohamed H. Abdel-Rahman, Dina Aziz, Sue Bell, Colleen M. Cebulla, Amy Davis, Rebecca Duell, J. Bradley Elder, Joe Hilty, Bahavna Kumar, James Lang, Norman L. Lehman, Randy Mandt, Phuong Nguyen, Robert Pilarski, Karan Rai, Lynn Schoenfield, Kelly Senecal, Paul Wakely, Paul Hansen, Ronald Lechan, James Powers, Arthur Tischler, William E. Grizzle, Katherine C. Sexton, Alison Kastl, Joel Henderson, Sima Porten, Jens Waldmann, Martin Fassnacht, Sylvia L. Asa, Dirk Schadendorf, Marta Couce, Markus Graefen, Hartwig Huland, Guido Sauter, Thorsten Schlomm, Ronald Simon, Pierre Tennstedt, Oluwole Olabode, Mark Nelson, Oliver Bathe, Peter R. Carroll, June M. Chan, Philip Disaia, Pat Glenn, Robin K. Kelley, Charles N. Landen, Joanna Phillips, Michael Prados, Jeffry Simko, Karen Smith-McCune, Scott VandenBerg, Kevin Roggin, Ashley Fehrenbach, Ady Kendler, Suzanne Sifri, Ruth Steele, Antonio Jimeno, Francis Carey, Ian Forgie, Massimo Mannelli, Michael Carney, Brenda Hernandez, Benito Campos, Christel Herold-Mende, Christin Jungk, Andreas Unterberg, Andreas von Deimling, Aaron Bossler, Joseph Galbraith, Laura Jacobus, Michael Knudson, Tina Knutson, Deqin Ma, Mohammed Milhem, Rita Sigmund, Andrew K. Godwin, Rashna Madan, Howard G. Rosenthal, Clement Adebamowo, Sally N. Adebamowo, Alex Boussioutas, David Beer, Thomas Giordano, Anne-Marie Mes-Masson, Fred Saad, Therese Bocklage, Lisa Landrum, Robert Mannel, Kathleen Moore, Katherine Moxley, Russel Postier, Joan Walker, Rosemary Zuna, Michael Feldman, Federico Valdivieso, Rajiv Dhir, James Luketich, Edna M. Mora Pinero, Mario Quintero-Aguilo, Carlos Gilberto Carlotti, Jose Sebastião Dos Santos, Rafael Kemp, Ajith Sankarankuty, Daniela Tirapelli, James Catto, Kathy Agnew, Elizabeth Swisher, Jenette Creaney, Bruce Robinson, Carl Simon Shelley, Eryn M. Godwin, Sara Kendall, Cassaundra Shipman, Carol Bradford, Thomas Carey, Andrea Haddad, Jeffey Moyer, Lisa Peterson, Mark Prince, Laura Rozek, Gregory Wolf, Rayleen Bowman, Kwun M. Fong, Ian Yang, Robert Korst, W. Kimryn Rathmell, J. Leigh Fantacone-Campbell, Jeffrey A. Hooke, Albert J. Kovatich, Craig D. Shriver, John DiPersio, Bettina Drake, Ramaswamy Govindan, Sharon Heath, Timothy Ley, Brian Van Tine, Peter Westervelt, Mark A. Rubin, Jung Il Lee, Natália D. Aredes, Armaz Mariamidze, Cancer Genome Atlas Research Network, Caesar-Johnson, S.J., Demchok, J.A., Felau, I., Kasapi, M., Ferguson, M.L., Hutter, C.M., Sofia, H.J., Tarnuzzer, R., Wang, Z., Yang, L., Zenklusen, J.C., Zhang, J.J., Chudamani, S., Liu, J., Lolla, L., Naresh, R., Pihl, T., Sun, Q., Wan, Y., Wu, Y., Cho, J., DeFreitas, T., Frazer, S., Gehlenborg, N., Getz, G., Heiman, D.I., Kim, J., Lawrence, M.S., Lin, P., Meier, S., Noble, M.S., Saksena, G., Voet, D., Zhang, H., Bernard, B., Chambwe, N., Dhankani, V., Knijnenburg, T., Kramer, R., Leinonen, K., Liu, Y., Miller, M., Reynolds, S., Shmulevich, I., Thorsson, V., Zhang, W., Akbani, R., Broom, B.M., Hegde, A.M., Ju, Z., Kanchi, R.S., Korkut, A., Li, J., Liang, H., Ling, S., Liu, W., Lu, Y., Mills, G.B., Ng, K.S., Rao, A., Ryan, M., Wang, J., Weinstein, J.N., Zhang, J., Abeshouse, A., Armenia, J., Chakravarty, D., Chatila, W.K., de Bruijn, I., Gao, J., Gross, B.E., Heins, Z.J., Kundra, R., La, K., Ladanyi, M., Luna, A., Nissan, M.G., Ochoa, A., Phillips, S.M., Reznik, E., Sanchez-Vega, F., Sander, C., Schultz, N., Sheridan, R., Sumer, S.O., Sun, Y., Taylor, B.S., Anur, P., Peto, M., Spellman, P., Benz, C., Stuart, J.M., Wong, C.K., Yau, C., Hayes, D.N., Parker, J.S., Wilkerson, M.D., Ally, A., Balasundaram, M., Bowlby, R., Brooks, D., Carlsen, R., Chuah, E., Dhalla, N., Holt, R., Jones, SJM, Kasaian, K., Lee, D., Ma, Y., Marra, M.A., Mayo, M., Moore, R.A., Mungall, A.J., Mungall, K., Robertson, A.G., Sadeghi, S., Schein, J.E., Sipahimalani, P., Tam, A., Thiessen, N., Tse, K., Wong, T., Berger, A.C., Beroukhim, R., Cherniack, A.D., Cibulskis, C., Gabriel, S.B., Gao, G.F., Ha, G., Meyerson, M., Schumacher, S.E., Shih, J., Kucherlapati, M.H., Kucherlapati, R.S., Baylin, S., Cope, L., Danilova, L., Bootwalla, M.S., Lai, P.H., Maglinte, D.T., Van Den Berg, D.J., Weisenberger, D.J., Auman, J.T., Balu, S., Bodenheimer, T., Fan, C., Hoadley, K.A., Hoyle, A.P., Jefferys, S.R., Jones, C.D., Meng, S., Mieczkowski, P.A., Mose, L.E., Perou, A.H., Perou, C.M., Roach, J., Shi, Y., Simons, J.V., Skelly, T., Soloway, M.G., Tan, D., Veluvolu, U., Fan, H., Hinoue, T., Laird, P.W., Shen, H., Zhou, W., Bellair, M., Chang, K., Covington, K., Creighton, C.J., Dinh, H., Doddapaneni, H., Donehower, L.A., Drummond, J., Gibbs, R.A., Glenn, R., Hale, W., Han, Y., Hu, J., Korchina, V., Lee, S., Lewis, L., Li, W., Liu, X., Morgan, M., Morton, D., Muzny, D., Santibanez, J., Sheth, M., Shinbrot, E., Wang, L., Wang, M., Wheeler, D.A., Xi, L., Zhao, F., Hess, J., Appelbaum, E.L., Bailey, M., Cordes, M.G., Ding, L., Fronick, C.C., Fulton, L.A., Fulton, R.S., Kandoth, C., Mardis, E.R., McLellan, M.D., Miller, C.A., Schmidt, H.K., Wilson, R.K., Crain, D., Curley, E., Gardner, J., Lau, K., Mallery, D., Morris, S., Paulauskis, J., Penny, R., Shelton, C., Shelton, T., Sherman, M., Thompson, E., Yena, P., Bowen, J., Gastier-Foster, J.M., Gerken, M., Leraas, K.M., Lichtenberg, T.M., Ramirez, N.C., Wise, L., Zmuda, E., Corcoran, N., Costello, T., Hovens, C., Carvalho, A.L., de Carvalho, A.C., Fregnani, J.H., Longatto-Filho, A., Reis, R.M., Scapulatempo-Neto, C., Silveira, HCS, Vidal, D.O., Burnette, A., Eschbacher, J., Hermes, B., Noss, A., Singh, R., Anderson, M.L., Castro, P.D., Ittmann, M., Huntsman, D., Kohl, B., Le, X., Thorp, R., Andry, C., Duffy, E.R., Lyadov, V., Paklina, O., Setdikova, G., Shabunin, A., Tavobilov, M., McPherson, C., Warnick, R., Berkowitz, R., Cramer, D., Feltmate, C., Horowitz, N., Kibel, A., Muto, M., Raut, C.P., Malykh, A., Barnholtz-Sloan, J.S., Barrett, W., Devine, K., Fulop, J., Ostrom, Q.T., Shimmel, K., Wolinsky, Y., Sloan, A.E., De Rose, A., Giuliante, F., Goodman, M., Karlan, B.Y., Hagedorn, C.H., Eckman, J., Harr, J., Myers, J., Tucker, K., Zach, L.A., Deyarmin, B., Hu, H., Kvecher, L., Larson, C., Mural, R.J., Somiari, S., Vicha, A., Zelinka, T., Bennett, J., Iacocca, M., Rabeno, B., Swanson, P., Latour, M., Lacombe, L., Têtu, B., Bergeron, A., McGraw, M., Staugaitis, S.M., Chabot, J., Hibshoosh, H., Sepulveda, A., Su, T., Wang, T., Potapova, O., Voronina, O., Desjardins, L., Mariani, O., Roman-Roman, S., Sastre, X., Stern, M.H., Cheng, F., Signoretti, S., Berchuck, A., Bigner, D., Lipp, E., Marks, J., McCall, S., McLendon, R., Secord, A., Sharp, A., Behera, M., Brat, D.J., Chen, A., Delman, K., Force, S., Khuri, F., Magliocca, K., Maithel, S., Olson, J.J., Owonikoko, T., Pickens, A., Ramalingam, S., Shin, D.M., Sica, G., Van Meir, E.G., Eijckenboom, W., Gillis, A., Korpershoek, E., Looijenga, L., Oosterhuis, W., Stoop, H., van Kessel, K.E., Zwarthoff, E.C., Calatozzolo, C., Cuppini, L., Cuzzubbo, S., DiMeco, F., Finocchiaro, G., Mattei, L., Perin, A., Pollo, B., Chen, C., Houck, J., Lohavanichbutr, P., Hartmann, A., Stoehr, C., Stoehr, R., Taubert, H., Wach, S., Wullich, B., Kycler, W., Murawa, D., Wiznerowicz, M., Chung, K., Edenfield, W.J., Martin, J., Baudin, E., Bubley, G., Bueno, R., De Rienzo, A., Richards, W.G., Kalkanis, S., Mikkelsen, T., Noushmehr, H., Scarpace, L., Girard, N., Aymerich, M., Campo, E., Giné, E., Guillermo, A.L., Van Bang, N., Hanh, P.T., Phu, B.D., Tang, Y., Colman, H., Evason, K., Dottino, P.R., Martignetti, J.A., Gabra, H., Juhl, H., Akeredolu, T., Stepa, S., Hoon, D., Ahn, K., Kang, K.J., Beuschlein, F., Breggia, A., Birrer, M., Bell, D., Borad, M., Bryce, A.H., Castle, E., Chandan, V., Cheville, J., Copland, J.A., Farnell, M., Flotte, T., Giama, N., Ho, T., Kendrick, M., Kocher, J.P., Kopp, K., Moser, C., Nagorney, D., O'Brien, D., O'Neill, B.P., Patel, T., Petersen, G., Que, F., Rivera, M., Roberts, L., Smallridge, R., Smyrk, T., Stanton, M., Thompson, R.H., Torbenson, M., Yang, J.D., Zhang, L., Brimo, F., Ajani, J.A., Gonzalez, AMA, Behrens, C., Bondaruk, J., Broaddus, R., Czerniak, B., Esmaeli, B., Fujimoto, J., Gershenwald, J., Guo, C., Lazar, A.J., Logothetis, C., Meric-Bernstam, F., Moran, C., Ramondetta, L., Rice, D., Sood, A., Tamboli, P., Thompson, T., Troncoso, P., Tsao, A., Wistuba, I., Carter, C., Haydu, L., Hersey, P., Jakrot, V., Kakavand, H., Kefford, R., Lee, K., Long, G., Mann, G., Quinn, M., Saw, R., Scolyer, R., Shannon, K., Spillane, A., Stretch, J., Synott, M., Thompson, J., Wilmott, J., Al-Ahmadie, H., Chan, T.A., Ghossein, R., Gopalan, A., Levine, D.A., Reuter, V., Singer, S., Singh, B., Tien, N.V., Broudy, T., Mirsaidi, C., Nair, P., Drwiega, P., Miller, J., Smith, J., Zaren, H., Park, J.W., Hung, N.P., Kebebew, E., Linehan, W.M., Metwalli, A.R., Pacak, K., Pinto, P.A., Schiffman, M., Schmidt, L.S., Vocke, C.D., Wentzensen, N., Worrell, R., Yang, H., Moncrieff, M., Goparaju, C., Melamed, J., Pass, H., Botnariuc, N., Caraman, I., Cernat, M., Chemencedji, I., Clipca, A., Doruc, S., Gorincioi, G., Mura, S., Pirtac, M., Stancul, I., Tcaciuc, D., Albert, M., Alexopoulou, I., Arnaout, A., Bartlett, J., Engel, J., Gilbert, S., Parfitt, J., Sekhon, H., Thomas, G., Rassl, D.M., Rintoul, R.C., Bifulco, C., Tamakawa, R., Urba, W., Hayward, N., Timmers, H., Antenucci, A., Facciolo, F., Grazi, G., Marino, M., Merola, R., de Krijger, R., Gimenez-Roqueplo, A.P., Piché, A., Chevalier, S., McKercher, G., Birsoy, K., Barnett, G., Brewer, C., Farver, C., Naska, T., Pennell, N.A., Raymond, D., Schilero, C., Smolenski, K., Williams, F., Morrison, C., Borgia, J.A., Liptay, M.J., Pool, M., Seder, C.W., Junker, K., Omberg, L., Dinkin, M., Manikhas, G., Alvaro, D., Bragazzi, M.C., Cardinale, V., Carpino, G., Gaudio, E., Chesla, D., Cottingham, S., Dubina, M., Moiseenko, F., Dhanasekaran, R., Becker, K.F., Janssen, K.P., Slotta-Huspenina, J., Abdel-Rahman, M.H., Aziz, D., Bell, S., Cebulla, C.M., Davis, A., Duell, R., Elder, J.B., Hilty, J., Kumar, B., Lang, J., Lehman, N.L., Mandt, R., Nguyen, P., Pilarski, R., Rai, K., Schoenfield, L., Senecal, K., Wakely, P., Hansen, P., Lechan, R., Powers, J., Tischler, A., Grizzle, W.E., Sexton, K.C., Kastl, A., Henderson, J., Porten, S., Waldmann, J., Fassnacht, M., Asa, S.L., Schadendorf, D., Couce, M., Graefen, M., Huland, H., Sauter, G., Schlomm, T., Simon, R., Tennstedt, P., Olabode, O., Nelson, M., Bathe, O., Carroll, P.R., Chan, J.M., Disaia, P., Glenn, P., Kelley, R.K., Landen, C.N., Phillips, J., Prados, M., Simko, J., Smith-McCune, K., VandenBerg, S., Roggin, K., Fehrenbach, A., Kendler, A., Sifri, S., Steele, R., Jimeno, A., Carey, F., Forgie, I., Mannelli, M., Carney, M., Hernandez, B., Campos, B., Herold-Mende, C., Jungk, C., Unterberg, A., von Deimling, A., Bossler, A., Galbraith, J., Jacobus, L., Knudson, M., Knutson, T., Ma, D., Milhem, M., Sigmund, R., Godwin, A.K., Madan, R., Rosenthal, H.G., Adebamowo, C., Adebamowo, S.N., Boussioutas, A., Beer, D., Giordano, T., Mes-Masson, A.M., Saad, F., Bocklage, T., Landrum, L., Mannel, R., Moore, K., Moxley, K., Postier, R., Walker, J., Zuna, R., Feldman, M., Valdivieso, F., Dhir, R., Luketich, J., Pinero, EMM, Quintero-Aguilo, M., Carlotti, C.G., Dos Santos, J.S., Kemp, R., Sankarankuty, A., Tirapelli, D., Catto, J., Agnew, K., Swisher, E., Creaney, J., Robinson, B., Shelley, C.S., Godwin, E.M., Kendall, S., Shipman, C., Bradford, C., Carey, T., Haddad, A., Moyer, J., Peterson, L., Prince, M., Rozek, L., Wolf, G., Bowman, R., Fong, K.M., Yang, I., Korst, R., Rathmell, W.K., Fantacone-Campbell, J.L., Hooke, J.A., Kovatich, A.J., Shriver, C.D., DiPersio, J., Drake, B., Govindan, R., Heath, S., Ley, T., Van Tine, B., Westervelt, P., Rubin, M.A., Lee, J.I., Aredes, N.D., Mariamidze, A., SAIC-F-Frederick, Inc, and Leidos Biomedical Research, Inc.
- Subjects
0301 basic medicine ,Neuroblastoma RAS viral oncogene homolog ,Genetics and Molecular Biology (all) ,PATHOGENESIS ,pan-cancer ,PROTEIN ,Cancer Genome Atlas Research Network ,medicine.disease_cause ,computer.software_genre ,Genome ,Biochemistry ,Transcriptome ,Gene expression ,HRAS ,KRAS ,NF1 ,NRAS ,Ras ,TCGA ,drug sensitivity ,machine learning ,Neoplasms ,PRECISION ONCOLOGY ,lcsh:QH301-705.5 ,Regulation of gene expression ,PREVIOUSLY TREATED PATIENTS ,3. Good health ,Gene Expression Regulation, Neoplastic ,PHASE-II ,Life Sciences & Biomedicine ,Signal Transduction ,Biology ,Machine learning ,General Biochemistry, Genetics and Molecular Biology ,Article ,BRAF ,03 medical and health sciences ,Cell Line, Tumor ,medicine ,Biochemistry, Genetics and Molecular Biology (all) ,Humans ,Gene ,SIGNATURES ,Science & Technology ,business.industry ,Genome, Human ,MUTATIONS ,EXPRESSÃO GÊNICA ,Cell Biology ,SELUMETINIB ,GENE ,030104 developmental biology ,lcsh:Biology (General) ,Selumetinib ,ras Proteins ,Artificial intelligence ,business ,computer - Abstract
SUMMARY Precision oncology uses genomic evidence to match patients with treatment but often fails to identify all patients who may respond. The transcriptome of these “hidden responders” may reveal responsive molecular states. We describe and evaluate a machine-learning approach to classify aberrant pathway activity in tumors, which may aid in hidden responder identification. The algorithm integrates RNA-seq, copy number, and mutations from 33 different cancer types across The Cancer Genome Atlas (TCGA) PanCanAtlas project to predict aberrant molecular states in tumors. Applied to the Ras pathway, the method detects Ras activation across cancer types and identifies phenocopying variants. The model, trained on human tumors, can predict response to MEK inhibitors in wild-type Ras cell lines. We also present data that suggest that multiple hits in the Ras pathway confer increased Ras activity. The transcriptome is underused in precision oncology and, combined with machine learning, can aid in the identification of hidden responders., In Brief Way et al. develop a machine-learning approach using PanCanAtlas data to detect Ras activation in cancer. Integrating mutation, copy number, and expression data, the authors show that their method detects Ras-activating variants in tumors and sensitivity to MEK inhibitors in cell lines.
- Published
- 2018
50. Selection and Characterization of Vimentin-Binding Aptamer Motifs for Ovarian Cancer
- Author
-
David E. Volk, Anil K. Pillai, Hongyu Wang, Miguel-Angel Elizondo-Riojas, Andrea M Costello, and Xin Li
- Subjects
Aptamer ,Cell ,Fluorescent Antibody Technique ,Pharmaceutical Science ,Organic chemistry ,Vimentin ,Article ,Analytical Chemistry ,chemistry.chemical_compound ,QD241-441 ,Drug Discovery ,Biomarkers, Tumor ,medicine ,Humans ,Intermediate Filament Protein ,Nucleotide Motifs ,Physical and Theoretical Chemistry ,Ovarian Neoplasms ,Binding Sites ,Base Sequence ,biology ,Chemistry ,SELEX Aptamer Technique ,Cancer ,RNA ,aptamer ,Aptamers, Nucleotide ,Flow Cytometry ,medicine.disease ,Kinetics ,medicine.anatomical_structure ,ovarian cancer ,Biochemistry ,Chemistry (miscellaneous) ,Tumor progression ,binding motifs ,biology.protein ,Nucleic Acid Conformation ,Molecular Medicine ,Female ,DNA ,Protein Binding - Abstract
The application of aptamers in biomedicine is emerging as an essential technology in the field of cancer research. As small single-stranded DNA or RNA ligands with high specificity and low immunogenicity for their targets, aptamers provide many advantages in cancer therapeutics over protein-based molecules, such as antibodies. Vimentin is an intermediate filament protein that is overexpressed in endothelial cells of cancerous tissue. High expression levels of vimentin have been associated with increased capacity for migration and invasion of the tumor cells. We have selected and identified thioated aptamers with high specificity for vimentin using human ovarian cancer tissues. Tentative binding motifs were chosen for two vimentin aptamers based on predicted secondary structures. Each of these shorter, tentative binding motifs was synthesized, purified, and characterized via cell binding assays. Two vimentin binding motifs with high fidelity binding were selected and further characterized via cell and tissue binding assays, as well as flow cytometric analysis. The equilibrium binding constants of these small thioated aptamer constructs were also determined. Future applications for the vimentin binding aptamer motifs include conjugation of the aptamers to synthetic dyes for use in targeted imaging and therapy, and ultimately more detailed and precise monitoring of treatment response and tumor progression in ovarian pathology.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.